Teladoc Health (TDOC) 10-K 3 Mar 16 2015 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2015	Feb. 29, 2016
Document and Entity Information
Entity Registrant Name	Teladoc, Inc.
Entity Central Index Key	1,477,449
Document Type	10-K
Document Period End Date	Dec. 31, 2015
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Document Fiscal Year Focus	2,015
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Document Fiscal Period Focus	FY
Entity Common Stock, Shares Outstanding		38,564,807
Entity Public Float	$ 291,779,000

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
Current assets:
Cash and cash equivalents	$ 55,066	$ 46,436
Short-term investments	82,282
Accounts receivable, net of allowance of $1,812 and $1,785, respectively	12,134	6,839
Due from officer		253
Prepaid expenses and other current assets	2,096	966
Total current assets	151,578	54,494
Property and equipment, net	6,259	1,065
Goodwill	56,342	28,454
Intangible assets, net	15,265	7,530
Other assets	293	296
Total assets	229,737	91,839
Current liabilities:
Accounts payable	2,213	2,210
Accrued expenses and other current liabilities	8,197	3,918
Accrued compensation	6,326	3,358
Long-term bank and other debt-current	1,250	833
Total current liabilities	17,986	10,319
Other liabilities	6,775	2,767
Deferred taxes	1,185	482
Long term bank and other debt	$ 25,227	$ 25,040
Commitments and contingencies
Stockholders’ equity (deficit):
Common stock, $0.001 par value; 75,000,000 shares authorized as of December 31, 2015 and 2014; 38,524,922 shares and 2,037,999 shares issued and outstanding as of December 31, 2015 and 2014, respectively	$ 38	$ 2
Additional paid-in capital	309,078	4,953
Accumulated deficit	(130,510)	(72,490)
Accumulated other comprehensive loss	(42)
Total stockholders' (deficit) equity	178,564	(67,535)
Total liabilities, convertible preferred stock and stockholders' (deficit) equity	$ 229,737	91,839
Convertible Preferred Stock
Current liabilities:
Temporary equity, carrying amount		117,914
Redeemable Common Stock
Current liabilities:
Temporary equity, carrying amount		$ 2,852

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)	Dec. 31, 2015	Dec. 31, 2014
Allowance of Accounts receivable	$ 1,812,000	$ 1,785,000
Temporary equity, shares authorized		50,479,286
Temporary equity, shares outstanding		50,452,939
Temporary equity, liquidation preference		$ 117,913,630
Common stock par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	75,000,000	75,000,000
Common stock, shares issued	38,524,922	2,037,999
Common stock, shares outstanding	38,524,922	2,037,999
Convertible Preferred Stock
Temporary equity par value	$ 0.001	$ 0.001
Temporary equity, shares authorized	50,479,286	50,479,286
Temporary equity, shares issued	0	50,452,939
Temporary equity, shares outstanding	0	50,452,939
Temporary equity, liquidation preference		$ 117,914,000
Redeemable Common Stock
Temporary equity par value	$ 0.001	$ 0.001
Temporary equity, shares issued	0	113,294
Temporary equity, shares outstanding	0	113,294

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Consolidated Statements of Operations
Revenue	$ 77,384	$ 43,528	$ 19,906
Cost of revenue	21,041	9,929	4,186
Gross profit	56,343	33,599	15,720
Operating expenses:
Advertising and marketing	20,236	7,662	4,090
Sales	17,976	11,571	4,441
Technology and development	14,210	7,573	3,532
General and administrative	54,843	19,623	8,772
Depreciation and amortization	4,863	2,320	754
Loss from operations	(55,785)	(15,150)	(5,869)
Interest income (expense), net	(2,199)	(1,499)	(56)
Net loss before taxes	(57,984)	(16,649)	(5,925)
Income tax provision	36	388	94
Net loss	$ (58,020)	$ (17,037)	$ (6,019)
Net loss per share, basic and diluted	$ (2.91)	$ (10.25)	$ (8.05)
Weighted-average shares used to compute basic and diluted net loss per share	19,917,348	1,962,845	1,222,268
Unaudited pro forma basic and diluted net loss per share	$ (1.53)
Weighted-average shares used to compute basic and diluted pro forma net loss per share (unaudited)	37,817,061

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Consolidated Statements of Comprehensive Loss
Net loss	$ (58,020)	$ (17,037)	$ (6,019)
Other comprehensive loss, net of tax
Net change in unrealized losses on available-for-sale securities	(42)
Other comprehensive loss, net of tax	(42)
Comprehensive loss	$ (58,062)	$ (17,037)	$ (6,019)

CONSOLIDATED STATEMENTS OF CONV

CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($) $ in Thousands	Convertible Preferred Stock	Convertible Preferred Stock Series E	Convertible Preferred Stock Series F	Redeemable Common Stock	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Income	Total
Balance as of beginning of the period at Dec. 31, 2012	$ 53,130			$ 2,852
Balance as of beginning of the period (in shares) at Dec. 31, 2012	31,371,102			113,294
Temporary Equity
Issuance of preferred stock for cash, net of issuance costs		$ 14,803
Issuance of preferred stock for cash, net of issuance costs (in shares)		6,227,169
Accretion of preferred stock to redemption amount		$ 197
Preferred dividend	$ 3,624
Repurchase of convertible preferred and common stock	$ (99)
Repurchase of convertible preferred and common stock (in shares)	(7,985)
Balance as of end of the period at Dec. 31, 2013	$ 71,655			$ 2,852
Balance as of end of the period (in shares) at Dec. 31, 2013	37,590,286			113,294
Balance as of beginning of the period at Dec. 31, 2012					$ 1		$ (46,534)		$ (46,533)
Balance as of beginning of the period (in shares) at Dec. 31, 2012					565,162
Stockholders' Equity (Deficit)
Accretion of preferred stock						$ (197)			(197)
Repurchase of convertible preferred and common stock						28			28
Exercise of stock options						595			$ 595
Exercise of stock options (in shares)					737,597				737,597
Preferred dividend						(724)	(2,900)		$ (3,624)
Stock-based compensation						298			298
Net loss							(6,019)		(6,019)
Balance as of end of the period at Dec. 31, 2013					$ 1		(55,453)		(55,452)
Balance as of end of the period (in shares) at Dec. 31, 2013					1,302,759
Temporary Equity
Issuance of preferred stock for cash, net of issuance costs			$ 50,082
Issuance of preferred stock for cash, net of issuance costs (in shares)			11,329,068
Accretion of preferred stock to redemption amount			$ 168
Preferred dividend	$ 2,920
Preferred dividends retired and converted to Series F preferred stock	$ (6,892)					6,892			$ 6,892
Preferred dividends retired and converted to Series F preferred stock (in shares)	1,553,917
Repurchase of convertible preferred and common stock	$ (19)
Repurchase of convertible preferred and common stock (in shares)	(20,332)
Balance as of end of the period at Dec. 31, 2014	$ 117,914			$ 2,852
Balance as of end of the period (in shares) at Dec. 31, 2014	50,452,939	6,227,169	12,882,377	113,294					50,452,939
Stockholders' Equity (Deficit)
Accretion of preferred stock						(168)			$ (168)
Preferred dividends retired and converted to Series F preferred stock	$ (6,892)					6,892			6,892
Warrant issued						219			219
Repurchase of convertible preferred and common stock						(349)			(349)
Repurchase of convertible preferred and common stock (in shares)					(50,834)
Exercise of stock options					$ 1	746			$ 747
Exercise of stock options (in shares)					786,074				786,074
Preferred dividend						(2,920)			$ (2,920)
Stock-based compensation						533			533
Net loss							(17,037)		(17,037)
Balance as of end of the period at Dec. 31, 2014					$ 2	4,953	(72,490)		(67,535)
Balance as of end of the period (in shares) at Dec. 31, 2014					2,037,999
Temporary Equity
Conversion of convertible preferred stock	$ (117,914)
Conversion of convertible preferred stock (in shares)	(50,452,939)
Conversion of redeemable common stock				$ (2,852)
Conversion of redeemable common stock (in shares)				(113,294)
Balance as of end of the period (in shares) at Dec. 31, 2015	0			0
Stockholders' Equity (Deficit)
Exercise of stock options						428			$ 428
Exercise of stock options (in shares)					270,545				270,545
Exercise of warrants						(1)			$ (1)
Exercise of warrants (in shares)					114,111
Issuance of stock in acquisition					$ 1	16,774			16,775
Issuance of stock in acquisition (in shares)					1,051,033
Issuance of stock in connection with IPO, net of $17,144 issuance costs					$ 9	163,109			163,118
Issuance of stock in connection with IPO, net of $17,144 issuance costs (in shares)					9,487,500
Conversion of convertible preferred stock					$ 26	117,888			117,914
Conversion of convertible preferred stock (in shares)					25,450,440
Conversion of redeemable common stock						2,852			2,852
Conversion of redeemable common stock (in shares)					113,294
Stock-based compensation						3,075			3,075
Other comprehensive income, net of tax								$ (42)	(42)
Net loss							(58,020)		(58,020)
Balance as of end of the period at Dec. 31, 2015					$ 38	$ 309,078	$ (130,510)	$ (42)	$ 178,564
Balance as of end of the period (in shares) at Dec. 31, 2015					38,524,922

CONSOLIDATED STATEMENTS OF CON7

CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) Parenthetical $ in Thousands	12 Months Ended
	Dec. 31, 2015USD ($)
Consolidated Statement of Convertible Preferred Stock and Stockholders' Equity (Deficit)
Stock issuance cost in connection with IPO	$ 17,144

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Cash flows used in operating activities:
Net loss	$ (58,020)	$ (17,037)	$ (6,019)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	4,863	2,320	754
Allowance for doubtful accounts	2,034	1,308	504
Stock-based compensation	3,075	533	298
Deferred income taxes	36	388	94
Accretion of interest	460	106	2
Impairment of long-lived assets	798
Changes in operating assets and liabilities:
Accounts receivable	(6,795)	(5,079)	(928)
Due from officer	253		(253)
Prepaid expenses and other current assets	(1,210)	(436)	(663)
Other assets	5	(185)	37
Accounts payable	(612)	2,099	(1,099)
Accrued expenses and other current liabilities	3,457	(26)	329
Accrued compensation	2,887	1,971	802
Other liabilities	1,588	2,679	89
Net cash used in operating activities	(47,181)	(11,359)	(6,053)
Cash flows used in investing activities:
Purchase of property and equipment	(6,275)	(1,069)	(204)
Purchase of internal software	(1,542)	(665)	(1,090)
Purchase of marketable securities	(103,030)
Proceeds from the liquidation/maturity of marketable securities	20,411
Acquisition of business, net of cash acquired	(17,767)	(13,844)	(16,462)
Net cash used in investing activities	(108,203)	(15,578)	(17,756)
Cash flows from financing activities:
Proceeds from the exercise of stock options and warrants	428	747	595
Proceeds from issuance of convertible preferred stock		50,082	14,803
Proceeds from borrowing under bank and other debt	6,800	19,700	3,000
Repayment of bank and other debt	(6,332)
Proceeds from issuance of common stock under IPO	163,118
Repurchase of stock		(368)	(71)
Net cash provided by financing activities	164,014	70,161	18,327
Net increase (decrease) in cash and cash equivalents	8,630	43,224	(5,482)
Cash and cash equivalents at beginning of year	46,436	3,212	8,694
Cash and cash equivalents at end of year	55,066	46,436	3,212
Interest paid:	$ 1,995	$ 1,191	$ 32

Organization and Description of

Organization and Description of Business	12 Months Ended
	Dec. 31, 2015
Organization and Description of Business
Organization and Description of Business	Note 1. Organization and Description of Business Teladoc, Inc. (together with its consolidated subsidiaries, “Teladoc”, or the “Company”) was incorporated in the State of Texas in June 2002 and changed its state of incorporation to the State of Delaware in October 2008. The Company’s principal executive offices are located in Purchase, New York and Dallas, Texas. Teladoc is the nation’s largest telehealth company. On July 7, 2015, Teladoc closed on its initial public offering (the “IPO”) in which the Company issued and sold 9,487,500 shares of common stock, including the exercise of an underwriter option to purchase additional shares, at an issuance price of $19.00 per share. The Company received net proceeds of $163.1 million after deducting underwriting discounts and commissions of $12.6 million as well as other offering expenses of $4.5 million. On July 7, 2015, all of the Company’s then-outstanding convertible preferred stock converted into an aggregate of 25.5 million shares of common stock and all of the Company’s redeemable common stock converted into 113,294 shares of common stock. The Company completed the acquisition of Consult A Doctor in 2013 (“CADR”), AmeriDoc, LLC (“AmeriDoc”) in 2014, Compile, Inc. d/b/a BetterHelp (“BetterHelp”) and Stat Health Services Inc. (“StatDoc”) in 2015, three companies engaged in telehealth activities similar to those of Teladoc. Additionally in 2015, the Company acquired certain assets from Gateway to Provider Access, Inc. (“Gateway”) which is engaged in the marketing, selling and administering the Company’s services through other third parties. Upon the effective date of each respective merger, each entity merged with and into Teladoc.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2015
Summary of Significant Accounting Policies
Summary of Significant Accounting Policies	Note 2. Summary of Significant Accounting Policies Basis of Presentation and Principles of Consolidation These consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”). The consolidated financial statements include the results of Teladoc, a professional association and seven professional corporations: Teladoc Physicians, P.A., Teladoc Physicians, P.C. formed and operated in Alaska; Teladoc Physicians, P.C. formed and operated in California; Teladoc Physicians, P.C. formed and operated in Colorado; Teladoc Physicians, P.C. formed and operated in Michigan; Teladoc Physicians, P.C. formed and operated in New Jersey; Teladoc Physicians, P.C. formed and operated in New York; and Teladoc Physicians, P.C. formed and operated in North Carolina (collectively, the “Association”). Teladoc Physicians, P.A. is party to a Services Agreement by and among it and the seven professional corporations noted above pursuant to which each professional corporation provides services to Teladoc Physicians, P.A. Each professional corporation is established pursuant to the requirements of its respective domestic jurisdiction governing the corporate practice of medicine. The Company holds a variable interest in the Association which contracts with physicians and other health professionals in order to provide services to Teladoc. The Association is considered a variable interest entity (“VIE”) since it does not have sufficient equity to finance its activities without additional subordinated financial support. An enterprise having a controlling financial interest in a VIE, must consolidate the VIE if it has both power and benefits—that is, it has (1) the power to direct the activities of a VIE that most significantly impact the VIE’s economic performance (power) and (2) the obligation to absorb losses of the VIE that potentially could be significant to the VIE or the right to receive benefits from the VIE that potentially could be significant to the VIE (benefits). The Company has the power and rights to control all activities of the Association and funds and absorbs all losses of the VIE. Total revenue and net loss for the VIE were $13.9 million and $(7.3) million, $6.5 million and $(3.9) million and $3.3 million and $(1.0) million for the years ended December 31, 2015, 2014 and 2013, respectively. The VIE’s total assets were $2.4 million and $2.1 million at December 31, 2015 and 2014, respectively. Total liabilities for the VIE were $18.7 million and $11.2 million at December 31, 2015 and 2014, respectively. The VIE total stockholders’ deficit was $16.4 million and $9.1 million at December 31, 2015 and 2014, respectively. All significant intercompany transactions and balances have been eliminated. Business Combinations The Company accounts for its business combinations using the acquisition method of accounting. The cost of an acquisition is measured as the aggregate of the acquisition date fair values of the assets transferred and liabilities assumed by the Company to the sellers and equity instruments issued. Transaction costs directly attributable to the acquisition are expensed as incurred. Identifiable assets and liabilities acquired or assumed are measured separately at their fair values as of the acquisition date. The excess of (i) the total costs of acquisition over (ii) the fair value of the identifiable net assets of the acquiree is recorded as goodwill. Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. The Company bases its estimates on historical experience, current business factors, and various other assumptions that the Company believes are necessary to consider to form a basis for making judgments about the carrying values of assets and liabilities, the recorded amounts of revenue and expenses, and the disclosure of contingent assets and liabilities. The Company is subject to uncertainties such as the impact of future events, economic and political factors, and changes in the Company’s business environment; therefore, actual results could differ from these estimates. Accordingly, the accounting estimates used in the preparation of the Company’s consolidated financial statements will change as new events occur, as more experience is acquired, as additional information is obtained and as the Company’s operating environment evolves. Changes in estimates are made when circumstances warrant. Such changes in estimates and refinements in estimation methodologies are reflected in reported results of operations; if material, the effects of changes in estimates are disclosed in the notes to the consolidated financial statements. Significant estimates and assumptions by management affect the allowance for doubtful accounts, the carrying value of long ‑lived assets (including goodwill and intangible assets), the carrying value, capitalization and amortization of software development costs, client performance guarantees, the calculation of a contingent liability in connection with an earn ‑out, the provision for income taxes and related deferred tax accounts, certain accrued liabilities, revenue recognition, contingencies, litigation and related legal accruals and the value attributed to employee stock options and other stock ‑based awards. Segment Information The Company’s chief operating decision maker, its Chief Executive Officer (“CEO”), reviews the financial information presented on a consolidated basis for purposes of allocating resources and evaluating its financial performance. Accordingly, the Company has determined that it operates in a single reportable segment—health services. Revenue Recognition The Company offers two types of subscription access revenue contracts: (i) contracts that provide for a fixed monthly charge for access and unlimited visits per Member and (ii) contracts that provide for a fixed monthly charge for access and a contractually defined cost for each visit. Any visit fee revenue that is not included in the subscription access revenue is recognized when the service has been provided to the Member. The Company recognizes a substantial portion of its revenue from contracts that provide employers and health plans (“Clients”) with subscription access to the Company’s network of physicians and other healthcare professionals (“Providers”) on a subscription basis for a fixed monthly fee which entitles the Client’s employees and their beneficiaries (“Members”) to unlimited consultations (“visits”). The contracts are generally for a one ‑year term and have an automatic renewal feature for additional years. The Company commences revenue recognition for the subscription access service on the date that the services are made available to the Client and its Members, which is considered the implementation date, provided all of the following criteria are met: · there is an executed subscription agreement; · the Member has access to the service; · collection of the fees is reasonably assured; and · the amount of fees to be paid by the Client and Member is fixed and determinable. Subscription Access Revenue Subscription access revenue recognition commences on the date that the Company’s services are made available to the Client, which is considered the implementation date, provided all of the other criteria described above are met. Revenue is recognized over the term of the Client contract and is based on the terms in the Client contracts, which can provide for a variable periodic fee based upon the actual number of Members. Revenue From Visit Fees Revenue from visits is comprised of all revenue that is earned in connection with the completion of a visit. The Company recognizes revenue as the visits are completed. The Company’s contracts do not generally contain refund provisions for fees earned related to services performed. However, certain of the Company’s contracts include client performance guarantees that are based upon minimum Member utilization and guarantees by the Company for specific service level performance of the Company’s services. If client performance guarantees are not being realized, the Company deducts from revenue an estimate of the amount that will be due at the end of the respective client’s contractual period. The Company issued credits amounting to approximately $0.4 million for both of the years ended December 31, 2015 and 2014 and $0.2 million for the year ended December 31, 2013. Cost of Revenue Cost of revenue primarily consists of fees paid to the Providers, costs incurred in connection with the Company’s Provider network operations, which include employee ‑related expenses (including salaries and benefits) as well as costs related to the Company’s call center and medical malpractice insurance. Cash and Cash Equivalents Cash and cash equivalents consist of highly liquid investments with original maturities of three months or less from the date of purchase. The Company’s cash and cash equivalents generally consist of investments in money market funds. Cash and cash equivalents are stated at fair value. Short-Term Investments The Company holds short-term investments in marketable securities primarily consisting of corporate bonds, commercial paper and asset backed securities with maturities of less than one year. These short-term investments are classified as available-for-sale and are carried at fair value with unrealized gains or losses recorded as a separate component of stockholders’ equity (deficit) in accumulated other comprehensive loss. Realized gains or losses are recognized in the consolidated statements of operations upon disposition of the securities. As of December 31, 2015, there were no short-term investments that had been in a continuous loss position for more than 12 months. Actual maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. Realized gains for the year ended December 31, 2015 were less than $0.1 million and are included in interest income (expense), net in the Company’s consolidated statements of operations. There were no realized losses in 2015, 2014 and 2013. Accounts Receivable and Allowance for Doubtful Accounts Accounts receivable are recorded at the invoiced amount, net of allowances for doubtful accounts. The allowance for doubtful accounts is based on the Company’s assessment of the collectability of accounts. The Company regularly reviews the adequacy of the allowance for doubtful accounts by considering the age of each outstanding invoice and the collection history of each customer to determine whether a specific allowance is appropriate. Accounts receivable deemed uncollectable are charged against the allowance for doubtful accounts when identified. Property and Equipment Property and equipment are stated at cost less accumulated depreciation. Depreciation is recorded using the straight ‑line method over the estimated useful lives of the respective asset as follows: Computer equipment 3 years Furniture and equipment 5 years Leasehold improvements Shorter of the lease term or the estimated useful lives of the improvements Maintenance and repairs are charged to expense as incurred, and improvements are capitalized. When assets are retired or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gain or loss is reflected in the consolidated statement of operations in the period realized. Internal ‑Use Software Internal ‑use software is included in intangible assets and is amortized on a straight ‑line basis over 3 years. For the Company’s development costs related to its software development tools that enable its Members and Providers to interact, the Company capitalizes costs incurred during the application development stage. Costs related to minor upgrades, minor enhancements and maintenance activities are expensed as incurred. Goodwill and Intangible Assets Goodwill represents the excess of the purchase price over the fair value of the net tangible and intangible assets acquired in a business combination. Goodwill is not amortized, but is tested for impairment annually on October 1 or more frequently if events or changes in circumstances indicate that the asset may be impaired. The Company’s impairment tests are based on a single operating segment and reporting unit structure. The goodwill impairment test involves a two ‑ step process. The first step involves comparing the fair value of the Company’s reporting unit to its carrying value, including goodwill. The fair value of the reporting unit is estimated using a discounted cash flows analysis. If the carrying value of the reporting unit exceeds its fair value, the second step of the test is performed by comparing the carrying value of the goodwill in the reporting unit to its implied fair value. An impairment charge is recognized for the excess of the carrying value of goodwill over its implied fair value. The Company’s annual goodwill impairment test resulted in no impairment charges in any of the periods presented in the consolidated financial statements. Other intangible assets resulted from business acquisitions and include Client relationships, non ‑compete agreements and trademarks. Client relationships are amortized over a period of 2 to 10 years in relation to expected future cash flows, while non ‑compete agreements are amortized over a period of 3 to 5 years using the straight ‑line method. Trademarks are amortized over 3 years using the straight-line method. Long-lived assets (property and equipment, internally developed software, and intangible assets) used in operations are reviewed for impairment whenever events or changes in circumstances indicate that carrying amounts may not be recoverable. For long-lived assets to be held and used, the Company recognizes an impairment loss only if its carrying amount is not recoverable through its undiscounted cash flows and measures the impairment loss based on the difference between the carrying amount and fair value. In 2015 the Company impaired certain internally developed software as it is no longer being utilized. The impairment loss of $0.8 million is included in general and administrative expense in the consolidated statements of operations. There were no impairment losses in 2014 or 2013. Stock ‑Based Compensation Stock ‑based compensation is measured based on the grant ‑ date fair value of the awards and recognized on a straight ‑line basis over the period during which the employee is required to perform services in exchange for the award (generally the vesting period of the award). The Company estimates the fair value of employee stock options using the Black ‑Scholes option ‑pricing model. Income Taxes The Company accounts for income taxes using the liability method, under which deferred tax assets and liabilities are determined based on the future tax consequences attributable to differences between the financial reporting carrying amounts of existing assets and liabilities and their respective tax bases and tax credit carry forwards and net operating loss carryforwards. Deferred tax assets and liabilities are measured using the enacted tax rates that are expected to be in effect when the differences are expected to reverse. The Company assesses the likelihood that deferred tax assets will be recovered from future taxable income, and a valuation allowance is established when necessary to reduce deferred tax assets to the amounts more likely than not expected to be realized. The Company recognizes and measures uncertain tax positions using a two ‑ step approach. The first step is to evaluate the tax position taken or expected to be taken by determining if the weight of available evidence indicates that it is more likely than not that the tax position will be sustained in an audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% likely to be realized upon ultimate settlement. Significant judgment is required to evaluate uncertain tax positions. The Company evaluates its uncertain tax positions on a regular basis. Its evaluations are based on a number of factors, including changes in facts and circumstances, changes in tax law, correspondence with tax authorities during the course of audit and effective settlement of audit issues. The Company’s policy is to include interest and penalties related to unrecognized tax benefits as a component of interest income (expense), net in the consolidated statements of operations. Comprehensive Loss Comprehensive loss consists of net loss and unrealized gains or losses on short-term investments. Unrealized gains or losses are net of any reclassification adjustments for realized gains and losses included in the consolidated statements of operations. Warranties and Indemnification The Company’s arrangements generally include certain provisions for indemnifying Clients against liabilities if there is a breach of a Client’s data or if the Company’s service infringes a third party’s intellectual property rights. To date, the Company has not incurred any material costs as a result of such indemnifications. The Company has also agreed to indemnify its directors and executive officers for costs associated with any fees, expenses, judgments, fines and settlement amounts incurred by any of these persons in any action or proceeding to which any of those persons is, or is threatened to be, made a party by reason of the person’s service as a director or officer, including any action by the Company, arising out of that person’s services as a director or officer or that person’s services provided to any other company or enterprise at the Company’s request. The Company maintains director and officer liability insurance coverage that would generally enable it to recover a portion of any future amounts paid. The Company may also be subject to indemnification obligations by law with respect to the actions of its employees under certain circumstances and in certain jurisdictions. Advertising and Marketing Expenses Advertising and marketing include all communications and campaigns to the Company’s Clients and Members and related employees’ costs and are expensed as incurred. For the years ended December 31, 2015, 2014 and 2013, advertising expenses were $17.3 million, $6.0 million and $3.0 million, respectively. Concentrations of Risk and Significant Clients The Company’s financial instruments that are exposed to concentrations of credit risk consist primarily of cash and cash equivalents, and accounts receivable. Although the Company deposits its cash with multiple financial institutions, its deposits, at times, may exceed federally insured limits. During the year ended December 31, 2015, substantially all of the Company’s revenue was generated by Clients located in the United States. During the year ended 2014 and 2013, all of the Company’s revenue was generated by clients located in the United States. No Client represented over 10% of accounts receivable for the years ended December 31, 2015 and 2014 or revenues for the years ended December 31, 2015, 2014 and 2013. Reclassifications Certain prior year amounts have been reclassified to conform to the current year presentation. Seasonality The Company typically experiences the strongest increases in consecutive quarterly revenue during the fourth and first quarters of each year, which coincides with traditional annual benefit enrollment seasons. In particular, as a result of many Clients’ introduction of new services at the very end of a calendar year, or the start of each calendar year, the majority of the Company’s new Client contracts have an effective date of January 1. Additionally, as a result of national seasonal cold and flu trends, the Company experiences the highest level of visit fees during the first and fourth quarters of each year when compared to other quarters of the year. Conversely, the second quarter of the year has historically been the period of lowest utilization of the Company’s Provider network services relative to the other quarters of the year. Recently Issued and Adopted Accounting Pronouncements In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (Topic 606), to achieve a consistent application of revenue recognition within the U.S., resulting in a single revenue model to be applied by reporting companies under GAAP. Under the new model, recognition of revenue occurs when a customer obtains control of promised goods or services in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In addition, the revised guidance requires that reporting companies disclose the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. The revised guidance is effective for the Company beginning in the quarter ending March 31, 2018; early adoption is allowed. The revised guidance is required to be applied retrospectively to each prior reporting period presented or retrospectively with the cumulative effect of initially applying it recognized at the date of initial application. The Company is currently evaluating the transition method that will be elected and the potential effect of the revised guidance will have on the Company’s consolidated financial statements. In June 2014, the FASB issued ASU 2014-12, Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period , requiring that a performance target that affects vesting and that could be achieved after the requisite service period be treated as a performance condition. The amendments in this guidance are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. The Company is currently evaluating the potential impact of this guidance on the Company’s financial disclosures and results. In August 2014, the FASB issued ASU 2014-15, Presentation of Financial Statements—Going Concern . This guidance addresses management’s responsibility to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern and to provide related footnote disclosures. Management’s evaluation should be based on relevant conditions and events that are known and reasonably knowable at the date that the financial statements are issued. ASU 2014-15 is effective for interim or annual periods beginning after December 15, 2016. Early adoption is permitted. The Company does not expect to early adopt this guidance and is currently evaluating the impact of the adoption of this guidance on the Company’s financial disclosures and results. In April 2015, the FASB issued ASU 2015-03, Interest—Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs, which requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The revised guidance is effective for the Company beginning in the quarter ending March 31, 2016 and is required to be applied retrospectively. Early adoption is permitted. The Company has early adopted ASU 2015-03 which resulted in a $0.1 million and $0.2 million balance sheet reclassification as of December 31, 2015 and 2014, respectively. In September 2015, the FASB issued ASU 2015-16, Business Combinations - Simplifying the Accounting for Measurement-Period Adjustments (Topic 805). ASU 2015-16 requires that an acquirer recognize adjustments to provisional amounts that are identified during the measurement period in the reporting period in which the adjustment amounts are determined. ASU 2015-16 is effective for interim and annual periods beginning after December 15, 2015, with early adoption permitted, and is to be applied on a prospective basis. The Company is currently in the process of evaluating the impact of the adoption of this standard on the Company’s consolidated financial statements. In November 2015, the FASB issued ASU 2015-17, Income Taxes (Topic 740): Balance Sheet Classification of Deferred Taxes . ASU 2015-17 simplifies the presentation of deferred income taxes by eliminating the separate classification of deferred income tax liabilities and assets into current and noncurrent amounts in the consolidated balance sheet. The amendments in the update require that all deferred tax liabilities and assets be classified as noncurrent in the consolidated balance sheet. The amendments in this update are effective for annual periods beginning after December 15, 2016, and interim periods therein and may be applied either prospectively or retrospectively to all periods presented. Early adoption is permitted. The Company has early adopted this standard in the fourth quarter of 2015 on a retrospective basis. Prior periods have been retrospectively adjusted. As a result of the adoption of ASU 2015-17, the Company reclassified $12,000 between current deferred tax assets and n oncurrent deferred tax liabilities in the 2014 balance sheet . In January 2016, the FASB issued ASU 2016-01, Financial Instruments-Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities . ASU 2016-01 amends various aspects of the recognition, measurement, presentation, and disclosure for financial instruments. With respect to our consolidated financial statements, the most significant impact relates to the accounting for equity investments. It will impact the disclosure and presentation of financial assets and liabilities. ASU 2016-01 is effective for annual reporting periods, and interim periods within those years beginning after December 15, 2017. Early adoption by public entities is permitted only for certain provisions. The Company is currently in the process of evaluating the impact of the adoption of this standard on the Company’s consolidated financial statements.

Fair Value Measurements

Fair Value Measurements	12 Months Ended
	Dec. 31, 2015
Fair Value Measurements
Fair Value Measurements	Note 3. Fair Value Measurements The Company measures its financial assets and liabilities at fair value at each reporting period using a fair value hierarchy that requires it to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. A financial instrument’s classification within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Three levels of inputs may be used to measure fair value: Level 1—Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets. Level 2—Include other inputs that are directly or indirectly observable in the marketplace. Level 3—Unobservable inputs that are supported by little or no market activity. The Company measures its cash equivalents at fair value on a recurring basis. The Company classifies its cash equivalents within Level 1 because they are valued using observable inputs that reflect quoted prices for identical assets in active markets and quoted prices directly in active markets. The Company measures its short-term investments at fair value on a recurring basis and classifies such as Level 2. They are valued using observable inputs that reflect quoted prices directly or indirectly in active markets. The short-term investments amortized cost approximates fair value. The Company measures its contingent consideration at fair value on a recurring basis and classifies such as Level 3. The Company estimates the fair value of contingent consideration as the present value of the expected contingent payments, determined using the weighted probability of the possible payments. The following tables present information about the Company’s assets and liabilities that are measured at fair value on a recurring basis using the above input categories (in thousands): December 31, 2015 Level 1 Level 2 Level 3 Total Cash and cash equivalents $ $ — $ — $ Short-term investments $ — $ $ — $ Contingent liability (included in accrued expenses and other current liabilities and other liabilities) $ — $ — $ $ December 31, 2014 Level 1 Level 2 Level 3 Total Cash and cash equivalents $ $ — $ — $ There were no transfers between fair value measurement levels during the years ended December 31, 2015 and 2014. The change in fair value of the Company’s contingent liability is recorded in general and administrative expenses in the consolidated statements of operations. The following table reconciles the beginning and ending balance of the Company’s Level 3 contingent liability: Fair value at date of acquisition $ Payments earned Change in fair value Fair value at December 31, 2015 $

Lease Abandonment Charge

Lease Abandonment Charge	12 Months Ended
	Dec. 31, 2015
Lease Abandonment Charge
Lease Abandonment Charge	Note 4. Lease Abandonment Charge In connection with the Company’s abandonment of facilities in Dallas, Texas and Greenwich, Connecticut, the Company incurred $0.8 million, in lease abandonment charges during the year ended December 31, 2015, which is included within general and administrative expenses in the consolidated statement of operations. There were no lease abandonments in 2014 and 2013. The following table details the associated liability. The current portion of the liability of $0.4 million was recorded in accrued expenses and other current liabilities and the non-current portion of the liability of $0.1 million was recorded in other liabilities in the consolidated balance sheet (in thousands): Balance January 1, 2015 $ — Charged to expense Paid or settled Balance December 31, 2015 $

Business Acquisitions

Business Acquisitions	12 Months Ended
	Dec. 31, 2015
Business Acquisitions
Business Acquisitions	Note 5. Business Acquisitions On July 31, 2015, the Company acquired certain assets from Gateway for $1.5 million, subject to post-closing working capital adjustments as defined in the purchase agreement. Gateway is engaged in the marketing, selling and administering the Company’s services through other third parties and as a result, the price in excess of the net assets acquired (less than $0.1 million) was allocated to client relationships. The acquisition transaction costs were less than $0.1 million and were recorded in general and administrative expense. The acquisition was considered an asset acquisition for tax purposes. On June 17, 2015, the Company completed the acquisition of StatDoc through a merger in which StatDoc became a wholly-owned subsidiary of the Company. The aggregate merger consideration paid by the Company in connection with the acquisition was $30.1 million, which was comprised of $13.3 million of cash and $16.8 million of the Company’s common stock (or 1,051,033 shares), subject to post-closing working capital adjustments as defined in the Agreement and Plan of Merger governing the acquisition. During the quarter ended September 30, 2015, the post-closing working capital adjustment was finalized favorably to the Company in the amount of less than $0.1 million. Fair value of the common stock was determined based on market data from similar healthcare enterprises. StatDoc is a telemedicine provider, focused on managed care, health system and self-insured clients. The acquisition was considered a stock acquisition for tax purposes and as such, the goodwill resulting from this acquisition is not tax deductible. The total associated transaction costs of the acquisition were $0.3 million and were recorded in general and administrative expense. On January 23, 2015, the Company completed the acquisition of BetterHelp, through a merger in which BetterHelp became a wholly ‑owned subsidiary of the Company. The merger consideration paid by the Company in connection with this acquisition consisted of (i) $3.3 million net of cash acquired and (ii) earn ‑out payments equal to a percentage of the annual net revenue of the BetterHelp business for four years following closing. The Company computed the value of these future payments from internally produced revenue projections and recorded a contingent liability in the amount of $2.4 million which is considered as additional purchase consideration. The Company also issued an unsecured, subordinated promissory note in the amount of $1.0 million, with all principal and interest at a rate of 5% per annum being payable on the third anniversary of the closing to the selling shareholder and another executive of BetterHelp. If the employment of the promissory note holders is terminated, then they forfeit their right to receive the promissory note. As such, the Company has determined the promissory note to be compensatory and is accruing the expense over the service term. In December 2015, the Company agreed to pay the full amount plus interest in January 2016 and, as a result, accelerated the expense in 2015. BetterHelp was acquired to help the Company expand its operations in the direct ‑to ‑consumer behavioral health sector. The acquisition was considered a stock acquisition for tax purposes and as such, the goodwill resulting from this acquisition is not tax deductible. The total associated transaction costs of the acquisition were $0.1 million and were recorded in general and administrative expense. On May 1, 2014, the Company completed the acquisition of AmeriDoc, a company engaged in telehealth activities similar to Teladoc, through the purchase of 100% of AmeriDoc’s outstanding members’ interests for $17.2 million, net of cash acquired, including a $3.5 million promissory note and adjustments for working capital in the amount of $0.2 million. AmeriDoc was acquired to help the Company expand its initial investment in the local and regional insurance broker markets to reach clients that previously did not have access to the Company’s services. Upon the effective date of the merger, AmeriDoc merged with and into Teladoc. The acquisition was considered an asset acquisition for tax purposes and as such, the goodwill resulting from this acquisition is tax deductible. The total associated transaction costs of the acquisition were $0.2 million and were recorded in general and administrative expense. On August 29, 2013, the Company completed the acquisition of CADR, a company engaged in telehealth activities similar to Teladoc, through the purchase of 100% of CADR’s outstanding common stock for $16.6 million, net of cash acquired, including adjustments for a working capital in the amount of $0.2 million, which was paid in 2014. CADR was acquired to help the Company expand its presence into the local and regional insurance broker markets to reach Clients that previously did not have access to the Company’s services. Upon the effective date of the merger, CADR merged with and into Teladoc. The acquisition is considered an asset acquisition for tax purposes and as such, the goodwill resulting from this acquisition is tax deductible. The total associated transaction costs of the acquisition were $0.2 million and were recorded in general and administrative expense. The acquisitions described above were accounted for using the acquisition method of accounting, which requires, among other things, the assets acquired and the liabilities assumed be recognized at their fair values as of the acquisition date. The results of the acquisitions were integrated within the Company’s existing business on the respective aforementioned acquisition dates. The following table summarizes the fair value estimates of the assets acquired and liabilities assumed at each acquisition date. The Company, with the assistance of a third-party valuation expert, estimated the fair value of the acquired tangible and intangible assets. Identifiable assets acquired and liabilities assumed (in thousands): StatDoc BetterHelp AmeriDoc CADR Purchase price $ $ $ $ Less: Cash Accounts receivable Other assets Client relationships Non-compete agreements Internal software — — Trademarks — — — Accounts payable Deferred tax — — Other liabilities — Goodwill $ $ $ $ The amount allocated to goodwill reflects the benefits Teladoc expects to realize from the growth of the respective acquisitions operations. The Company’s unaudited pro forma revenue and net loss for the years ended December 31, 2015 and 2014 below have been prepared as if AmeriDoc, BetterHelp and StatDoc had been purchased on January 1, 2014. Unaudited pro forma financial statement results including the results of Gateway would not differ materially from the Company’s historically reported financial statement results. Unaudited Pro Forma (in thousands) 2015 2014 Revenue $ $ Net loss $ $ The unaudited pro forma financial information above is not necessarily indicative of what the Company’s consolidated results actually would have been if the acquisitions had been completed at the beginning of the respective periods. In addition, the unaudited pro forma information above does not attempt to project the Company’s future results.

Property and Equipment, Net

Property and Equipment, Net	12 Months Ended
	Dec. 31, 2015
Property and Equipment, Net
Property and Equipment, Net	Note 6. Property and Equipment, Net Property and equipment, net, consist of the following (in thousands): As of December 31, 2015 2014 Computer equipment $ $ Furniture and equipment Leasehold improvement — Construction in progress — Total Accumulated depreciation Property and equipment, net $ $ Depreciation expense for the years ended December 31, 2015, 2014 and 2013 was $1.1 million, $0.3 million and $0.2 million, respectively. As of December 31, 2015, construction in progress consisted pr imarily of costs incurred to establish a new hosting facility and purchased computer equipment, which was not placed into service.

Intangible Assets, Net

Intangible Assets, Net	12 Months Ended
	Dec. 31, 2015
Intangible Assets, Net
Intangible Assets, Net	Note 7. Intangible Assets, Net Intangible assets consist of the following (in thousands): Weighted Average Useful Accumulated Net Carrying Remaining Life Gross Value Amortization Value Useful Life December 31, 2015 Client relationships 2 to 10 years $ $ $ Non-compete agreements 3 to 5 years Trademarks 3 years Internal software 3 years Intangible assets, net $ $ $ December 31, 2014 Client relationships 10 years $ $ $ Non-compete agreements 3 to 5 years Internal software 3 years Intangible assets, net $ $ $ Amortization expense for intangible assets was $3.7 million, $2.0 million and $0.6 million for the years ended December 31, 2015, 2014 and 2013, respectively. During the year ended December 31, 2015, $0.8 million of internal software, net of accumulated amortization, was written-off. Periodic amortization that will be charged to expense over the remaining life of the intangible assets as of December 31, 2015 is as follows (in thousands): Years Ending December 31, 2016 $ 2017 2018 2019 2020 Thereafter $

Goodwill

Goodwill	12 Months Ended
	Dec. 31, 2015
Goodwill
Goodwill	Note 8. Goodwill Goodwill consists of the following (in thousands): As of December 31, 2015 2014 Beginning balance $ $ Additions associated with acquisitions Goodwill $ $

Accrued Expenses and Other Curr

Accrued Expenses and Other Current Liabilities	12 Months Ended
	Dec. 31, 2015
Accrued Expenses and Other Current Liabilities
Accrued Expenses and Other Current Liabilities	Note 9. Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consist of the following (in thousands): As of December 31, 2015 2014 Professional fees $ $ Consulting fees/cutomer service fees/provider fees Legal fees Interest payable Earnout and compensation — Lease abandonment — Deferred revenue — Other Total $ $

Long Term Bank and Other Debt

Long Term Bank and Other Debt	12 Months Ended
	Dec. 31, 2015
Long Term Bank and Other Debt
Long Term Bank and Other Debt	Note 10. Long Term Bank and Other Debt Long ‑term bank and other debt consist of the following (in thousands): As of December 31, 2015 2014 SVB Mezzanine Term Loan less debt discount of $190 and $327 $ $ SVB Term Loan Facility SVB Revolving Advance Facility Subordinated Promissory Note Total Less: current portion of SVB Term Loan Facility Long term bank and other debt $ $ Long term bank and other debt are stated at amortized cost, which approximates fair value. In May 2014, the Company entered into an Amended and Restated Loan and Security Agreement with Silicon Valley Bank (“SVB”) that provided for a Revolving Advance Facility and a Term Loan Facility (the “Amended Term Loan Facility”). The Revolving Advance Facility provides for borrowings up to $12.0 million based on 300% of the Company’s monthly recurring revenue. Borrowings under the Revolving Advance Facility were $6.5 million and $4.7 million at December 31, 2015 and 2014, respectively. The Revolving Advance Facility carries interest at a rate of 0.75% above the prime rate per annum and was to mature in April 2016. The Company entered into an amendment to the Revolving Advance Facility in March 2015 that extended its maturity to April 2017. Interest payments are payable monthly in arrears. In May 2015, the Company increased the borrowings to $11.5 million. On July 15, 2015, the Company reduced its indebtedness under the Revolving Advance Facility with a $5.0 million principal repayment. The Amended Term Loan Facility provides for borrowings up to $5.0 million. As of December 31, 2015 and 2014, the Company had utilized the total $5.0 million available under this Amended Term Loan Facility. The Amended Term Loan Facility carries interest at a rate of 1.00% above the prime rate per annum. Interest payments are payable monthly in arrears. Payments on the Amended Term Loan Facility commenced in May 2015 and continue with 47 equal monthly payments of principal plus interest. In May 2014, the Company entered into a Subordinated Loan and Security Agreement with SVB that provided for a Mezzanine Term Loan totaling $13.0 million. The total $13.0 million drawdown of the Mezzanine Term Loan was completed in September 2014. The Mezzanine Term Loan carries interest at a rate of 10.00% per annum and matures in May 2017. Interest payments are payable monthly in arrears. In connection with entry into the Mezzanine Term Loan, the Company granted two affiliates of SVB warrants to purchase an aggregate of 131,239 shares of common stock of the Company at an exercise price of $2.95 per share. The warrants were immediately exercisable and had a 10 ‑year term. See Note 14, “Common Stock and Stockholders’ Equity (Deficit)”, for more information. The Company also granted SVB a security interest in significantly all of the Company’s assets. The Mezzanine Term Loan has been used to fund the expansion of the Company’s business. The Amended and Restated Loan and Security Agreement with SVB and the Subordinated Loan and Security Agreement are collectively referred to as the “SVB Facilities.” The Company incurred approximately $0.3 million of loan origination costs in connection with the SVB facilities and amortized approximately $0.1 million of these costs during both years ended December 31, 2015 and 2014. Effective with the purchase of AmeriDoc, the Company executed a Subordinated Promissory Note in the amount of $3.5 million payable to the seller of AmeriDoc on April 30, 2015. The Subordinated Promissory Note carries interest at a rate of 10.00% annual interest and is subordinated to the SVB Facilities. In March 2015, the Company, the seller of AmeriDoc and SVB executed an Amended and Restated Subordinated Promissory Note that extended the maturity of the Amended and Restated Subordinated Promissory Note to April 30, 2017. In November 2015, the Company executed the Second Amended and Restated Subordinated Promissory Note with a revised annual interest rate of 7.00% commencing on January 1, 2016 and extended the maturity of the Promissory Note to April 30, 2018 with a seller put option at April 30, 2017. The Company repaid $0.5 million of principal on this Second Amended and Restated Subordinated Promissory Note during 2015. Payments due are as follows (in thousands): Total 2016 $ 2017 2018 2019 2020 and thereafter — Total $

Related Party Transaction

Related Party Transaction	12 Months Ended
	Dec. 31, 2015
Related Party Transaction
Related Party Transaction	Note 11. Related Party Transaction In May 2013, the Company issued a loan to an officer of the Company in the amount of $0.3 million. This was a non ‑cash transaction, whereby the loan proceeds were used to exercise options to purchase 312,474 shares of common stock options of the Company at an exercise price of $0.80 per share. The loan carries interest at the rate of 2% per annum and is due and payable upon the earlier of (i) May 13, 2017 and (ii) the occurrence of a “Change of Control” as defined in the promissory note evidencing the loan. The officer was required to make monthly interest payments. At December 31, 2014, the balance of the loan was $0.3 million. The loan was repaid in full to the Company in February 2015.

Leases and Contractual Obligati

Leases and Contractual Obligations	12 Months Ended
	Dec. 31, 2015
Leases and Contractual Obligations
Leases and Contractual Obligations	Note 12. Leases and Contractual Obligations Operating Leases The Company leases office space under non ‑cancelable operating leases in the United States. As of December 31, 2015, the future minimum lease payments under non ‑cancelable operating leases are as follows (in thousands): Operating Leases 2016 $ 2017 2018 2019 2020 2021 and thereafter $ All of the total future minimum lease payments relate to facilities space. The facility lease agreements generally provide for rental payments on a graduated basis and for options to renew, which could increase future minimum lease payments if exercised. The Company recognizes rent expense on a straight ‑line basis over the lease period and has accrued for rent expense incurred but not paid. Deferred rent represents the difference between actual operating lease payments due and straight ‑line rent expense. The excess is recorded as a deferred rent liability in the early periods of the lease, when cash payments are generally lower than straight ‑line rent expense, and are reduced in the later periods of the lease when payments begin to exceed the straight ‑line expense. The Company also accounts for leasehold improvement incentives within its deferred rent liability. For abandoned facilities, the above contractual obligation schedule does not reflect any realized or potential subleases. Rent expense for the years ended December 31, 2015, 2014 and 2013 was $1.3 million, $0.8 million and $0.5 million, respectively. Letter of Credit In November 2014, the Company arranged for SVB to issue a letter of credit on its behalf in the amount of $0.3 million in lieu of a cash deposit in connection with the Company’s Purchase, NY office lease. The letter of credit has been extended to November 2016. In connection with the Company lease agreement for office space near Dallas, Texas in February 2015, the Company arranged for SVB issued a letter of credit on its behalf in the amount of $1.0 million in lieu of a cash deposit. The letter of credit has been extended to February 2017.

Convertible Preferred Stock (th

Convertible Preferred Stock (the "Preferred Stock")	12 Months Ended
	Dec. 31, 2015
Convertible Preferred Stock (the "Preferred Stock")
Convertible Preferred Stock (the "Preferred Stock")	Note 13. Convertible Preferred Stock (the “Preferred Stock”) On July 7, 2015, all of the Company's then-outstanding convertible preferred stock converted into an aggregate of 25.5 million shares of common stock. The Preferred Stock consists of the following: Common Shares Shares Shares Upon Liquidation December 31, 2014 Authorized Outstanding Conversion Preference Series A $ Series A-1 Series B Series C-1 Series D Series E Series F $ As of December 31, 2014, the significant terms applicable to the Series A through Series F Preferred Stock were as follows: Dividend Rights Prior to the issuance of the Series F Preferred Stock, the Series A—E Preferred Stock accrued cumulative dividends at the per annum rate of 7.5% of the respective original purchase price (as previously adjusted for a reverse stock split and, with respect to the Series A, A ‑1 and B Preferred Stock, anti ‑dilution protection) for each such series of Preferred Stock. Such dividends were payable when, as and if declared by the Company’s board of directors, but prior and in preference to any dividend on the common stock of the Company. In connection with the issuance of the Series F Preferred Stock, all such accrued and accumulated dividends (which totaled approximately $13.8 million at August 31, 2014) were converted into Series F Preferred Stock at a rate of $0.50 of Series F Preferred Stock per $1.00 in accrued dividends, resulting in the issuance of approximately 1,554,000 shares of Series F Preferred Stock on September 10, 2014. There are no longer any accrued or unpaid dividends, or any outstanding Preferred Stock, and no such dividends are required to accrue or be declared by the Company. Conversion Rights Each share of Preferred Stock was convertible, at any time and at the option of the holder of such share, into shares of the common stock of the Company, at the following ratios (subject to adjustment as described below): Number of Shares of Common Stock Issued for each Preferred Share Upon Conversion Original Conversion (= Original Issue Price/ Series of Preferred Stock Issue Price Price Conversion Price) Series F $ $ Series E $ $ Series D $ $ Series C-1 $ $ Series B $ $ Series A-1 $ $ Series A $ $ The holders of a majority of the outstanding shares of the Preferred Stock (voting as a single class on an as-converted basis, including holders of at least a majority of the outstanding shares of Series F Preferred Stock) approved the automatic conversion of the Preferred Stock into common stock of the Company upon the closing of an IPO of the common stock of the Company at a per share price of at least $12.00 (prior to underwriting discounts and commissions) that results in aggregate proceeds to the Company of at least $75.0 million (net of underwriting discounts and commissions). Subject to limited exceptions, the conversion price for each series of the Preferred Stock was subject to an adjustment to reduce dilution in the event that the Company issued additional equity securities at a purchase price less than the applicable conversion price for such series of the Preferred Stock. Liquidation Rights In the event of any voluntary or involuntary liquidation, dissolution or winding up of the Company, the assets of the Company available for distribution will be distributed to the Company’s stockholders in the following order of priority: 1. First, the holders of Series F Preferred Stock will receive an amount per share equal to the sum of (i) the original issue price for the Series F Preferred Stock ($4.4355) , plus (ii) any declared but unpaid dividends on the Series F Preferred Stock (the “Series F Liquidation Amount”). 2. Second, the holders of Series E, D and C ‑1 Preferred Stock (pari passu) will receive an amount per share equal to the sum of (i) the original issue price for the Series E Preferred Stock ($2.4088) , Series D Preferred Stock ($1.507391) or Series C ‑1 Preferred Stock ($0.835) , as applicable, plus (ii) any declared but unpaid dividends on the Series E Preferred Stock, Series D Preferred Stock or Series C ‑1 Preferred Stock, as applicable (the “Series E Liquidation Amount,” the “Series D Liquidation Amount,” and the “Series C ‑1 Liquidation Amount,” respectively). 3. Third, the holders Series B Preferred Stock will receive an amount per share equal to the sum of (i) 1.23 times the original issue price (adjusted for a prior reverse stock split and anti ‑dilution protection) for the Series B Preferred Stock ( $17.775 ), plus (ii) any declared but unpaid dividends on the Series B Preferred Stock (the “Series B Liquidation Amount”). 4. Fourth, the holders of Series A and A ‑1 Preferred Stock (pari passu) will receive an amount per share equal to the greater of (x) the sum of (i) 1.25 times the original issue price (adjusted for a prior reverse stock split and anti ‑dilution protection) for the Series A Preferred Stock ( $10.00 ) or Series A ‑1 Preferred Stock ( $13.625 ), as applicable, plus (ii) any declared but unpaid dividends on the Series A Preferred Stock or Series A ‑1 Preferred Stock, as applicable, and (y) the aggregate amount that would have been payable in respect of number of common stock issued upon conversion of Series A and Series A ‑1 immediately prior to liquidation, dissolution or winding up of the Company, the “Series A Liquidation Amount” and the “Series A ‑1 Liquidation Amount,” respectively). 5. Following the payment in full of the amounts described above, the remaining assets of the Company will be distributed to the holders of Series F, E, D, C ‑1 and B Preferred Stock and common stock of the Company (but not Series A or A ‑1 Preferred Stock) pro rata based on the number of such shares held by each stockholder on an as ‑converted to common stock basis (as applicable, the “Participation Amount”). Notwithstanding the above: a. If the aggregate of the Series F Liquidation Amount and the Participation Amount payable with respect to the Series F Preferred Stock exceeds the sum of (i) 1.5 times the original issue price for the Series F Preferred Stock ( $4.4355 ), plus (ii) any declared but unpaid dividends thereon (collectively, the “Maximum Series F Liquidation Amount”), then holders of Series F Preferred Stock will instead receive the greater of (x) the Maximum Series F Liquidation Amount, or (y) the amount that such holders would receive if all shares of Series F Preferred Stock had been converted into common stock of the Company immediately prior to the liquidation, dissolution or winding up of the Company. b. If the aggregate of the Series E Liquidation Amount and the Participation Amount payable with respect to the Series E Preferred Stock exceeds the sum of (i) 3 times the original issue price for the Series E Preferred Stock ( $2.4088 ), plus (ii) any declared but unpaid dividends thereon (collectively, the “Maximum Series E Liquidation Amount”), then holders of Series E Preferred Stock will instead receive the greater of (x) the Maximum Series E Liquidation Amount, or (y) the amount that such holders would receive if all shares of Series E Preferred Stock had been converted into common stock of the Company immediately prior to the liquidation, dissolution or winding up of the Company. Subject to limited exceptions, unless waived by holders of at least (i) a majority of the outstanding shares of Preferred Stock (voting together as a single class on an as ‑converted to common stock basis), and (ii) a majority of the outstanding Series F Preferred Stock, a merger, combination, consolidation, or sale of voting control of the Company or sale or transfer of substantially all of the assets of the Company, in each case in which the Company’s stockholders do not own a majority of the voting shares of the surviving or acquiring corporation, will be deemed to be a liquidation event. If such deemed liquidation event is structured as a merger, combination, consolidation or sale of voting control, the proceeds of such transaction must be distributed to the stockholders in the order described above. If, alternatively, the deemed liquidation event is structured as a sale of assets, and the Company does not dissolve within 90 days after such deemed liquidation event, the holders of Preferred Stock may elect (pursuant to a procedure and in an order of priority similar to that described under “Redemption” below) to have their shares redeemed by the Company in exchange applicable Liquidation Amount described above. Protective Provisions Subject to limited exceptions and certain additional restrictions, so long as at least three million shares of Preferred Stock remain outstanding, the Company may not do any of the following without the consent of holders of a majority of the Preferred Stock (voting together as a single class on an as ‑converted to common stock basis): a. increase the authorized number of shares of any series of Preferred Stock or common stock of the Company; b. issue or obligate itself to issue shares of any additional class or series of capital stock unless the same ranks junior to the existing Preferred Stock; c. effect any transaction or series of related transactions resulting in the consummation of a merger, combination, consolidation or other reorganization of the Company with or into any third party, the transfer of all or substantially all of the assets of the Company to a third party, or any other change of control or recapitalization; d. subject to limited exceptions, purchase or redeem any shares of capital stock of the Company; e. amend, alter or repeal any provision of the Certificate of Incorporation or the Bylaws of the Company; f. sell or otherwise dispose of any of the Company’s or its subsidiaries’ material assets, other than (A) in the ordinary course of business or (B) to wholly ‑owned subsidiaries of the Company or its subsidiaries; g. liquidate, dissolve or wind ‑up the business and affairs of the Company; h. pay or declare any dividend other than as set forth in the Certificate of Incorporation of the Company; i. increase the number of shares of common stock or stock options of the Company authorized to be issued to employees or directors of, or consultants or advisors to, the Company or any of its subsidiaries; j. change the size of the Company’s board of directors; k. alter the rights or preferences of the Preferred Stock; l. issue any shares of Preferred Stock; m. subject to limited exceptions, issue any shares of common stock of the Company other than issuances approved by the Company’s board of directors (including the approval of the director appointed by the holders of Series D Preferred Stock and the director appointed by the holders of Series F Preferred Stock). Additionally, for so long as at least twenty ‑five percent ( 25% ) of the number of shares of any series of Preferred Stock remain issued and outstanding, the Company may not (i) take any action that materially and adversely alters the rights of such series of the Preferred Stock unless substantially similar action is taken with respect to all of the other series of the Preferred Stock or (ii) create any additional class or series of capital stock which ranks senior or pari passu to such series of the Preferred Stock, in each such case without the consent of the holders of a majority (which majority must, in certain cases, include the consent of certain named institutional investors) of the outstanding shares of the respective, affected series of the Preferred Stock, voting as a separate class. Redemption On and after September 1, 2019, the holders of shares Preferred Stock may require that such shares be redeemed by the Company out of lawfully available funds, as follows: 1) First, the holders of at least a majority of the Series F Preferred Stock (voting as a separate class) may require that all shares of Series F Preferred Stock be redeemed at a price equal to the sum of (i) the original issue price for the Series F Preferred Stock ( $4.4355 ), plus (ii) any declared or accrued but unpaid dividends thereon. 2) Second, and provided that all shares of Series F Preferred Stock have been redeemed by the Company, the Company’s Series E, D and C ‑1 Preferred Stock (acting pari passu but as separate classes), may be redeemed as follows: a) The holders of at least a majority of the Series E Preferred Stock (voting as a separate class) may require that all shares of Series E Preferred Stock be redeemed at a price equal to the sum of (i) the original issue price for the Series E Preferred Stock ( $2.4088 ), plus (ii) any declared or accrued but unpaid dividends thereon. b) The holders of at least a majority of the Series D Preferred Stock (voting as a separate class) may require that all shares of Series D Preferred Stock be redeemed at a price equal to the sum of (i) the original issue price for the Series D Preferred Stock ( $1.5074 ), plus (ii) any declared or accrued but unpaid dividends thereon. c) The holders of at least a majority of the Series C ‑1 Preferred Stock (voting as a separate class) may require that all shares of Series C ‑1 Preferred Stock be redeemed at a price equal to the sum of (i) the original issue price for the Series C ‑1 Preferred Stock ( $0.835 ), plus (ii) any declared or accrued but unpaid dividends thereon. 3) Third, and provided that all shares of Series F, D, E and C ‑1 Preferred Stock have been redeemed, the holders of a majority of the Series B Preferred Stock may require that all shares of Series B Preferred Stock be redeemed at a price equal to (i) 1.23 times the original issue price (adjusted for a prior reverse stock split and anti ‑dilution protection) for the Series B Preferred Stock ( $17.775 ), plus (ii) any declared but unpaid dividends thereon. 4) Fourth, and provided that all shares of Series F, D, E, C ‑1 and B Preferred Stock (as well as certain shares of Common Stock held by the holders of Series B Preferred Stock) have been redeemed, the holders of a majority of the Series A and A ‑1 Preferred Stock (voting together as a single class) may require that all shares of Series A and A ‑1 Preferred Stock be redeemed at a price equal to the sum of (i) 1.25 times the original issue price (adjusted for a prior reverse stock split and anti ‑dilution protection) for the Series A Preferred Stock ( $10.00 ) or Series A ‑1 Preferred Stock ( $13.625 ), as applicable, plus (ii) any declared but unpaid dividends on the Series A Preferred Stock or Series A ‑1 Preferred Stock, as applicable. At December 31, 2014 all shares of the Preferred Stock have been presented outside of permanent stockholders’ deficit, because there were redemption events outside of the Company’s control.

Common Stock and Stockholders_

Common Stock and Stockholders’ Equity (Deficit)	12 Months Ended
	Dec. 31, 2015
Common Stock and Stockholders’ Equity (Deficit)
Common Stock and Stockholders’ Equity (Deficit)	Note 14. Common Stock and Stockholders’ Equity (Deficit) Capitalization On July 7, 2015, Teladoc completed its IPO in which the Company issued and sold 9,487,500 shares of common stock, including the exercise of an underwriter option to purchase additional shares, at an issuance price of $19.00 per share. The Company received net proceeds of $163.1 million after deducting underwriting discounts and commissions of $12.6 million as well as other offering expenses of $4.5 million. On June 17, 2015, the Company filed a Certificate of Amendment to the Company’s Certificate of Incorporation to effect a one ‑for ‑2.2859 reverse stock split of all outstanding shares of common stock with the Secretary of State of the State of Delaware. The Certificate of Amendment provides that every 2.2859 shares of the Company’s issued and outstanding common stock automatically combine into one issued and outstanding share of the Company’s common stock. The Certificate of Amendment did not change the par value of the Company’s common stock and preferred stock. All shares and per share amounts in the consolidated financial statements and accompanying notes have been retroactively adjusted to give effect to the reverse stock split. In addition, the Certificate of Amendment increased the number of authorized shares of the Company’s common stock to 75,000,000 shares and the number of authorized shares of the Company’s preferred stock to 50,479,286 shares. Additionally, the holders of a majority of the outstanding shares of the Preferred Stock (voting as a single class on an as ‑converted basis, including holders of at least a majority of the outstanding shares of Series F Preferred Stock) approved the automatic conversion of the Preferred Stock into common stock of the Company upon the closing of an IPO of the common stock of the Company at a per share price of at least $12.00 (prior to underwriting discounts and commissions) that results in aggregate proceeds to the Company of at least $75.0 million (net of underwriting discounts and commissions). On July 7, 2015, all of the Company’s then-outstanding convertible preferred stock converted into an aggregate of 25.5 million shares of common stock and all of the Company’s redeemable common stock converted into 113,294 shares of common stock. Redeemable Common Stock The holders of at least a majority of the Preferred Stock have agreed that, following the redemption of all the Preferred Stock, the total 59,048 shares of Series A Common Stock will be subject to a redemption price equal to the greater of (i) the sum of (A) 2.25 times 2.2859 times the Series A Investors Common Stock price, plus (B) any dividends declared but unpaid thereon and (ii) the Series A Investors Common Stock appraised value. The holders of at least a majority of the Preferred Stock have agreed that, following the redemption of all the Preferred Stock, the total 54,246 shares of Series B Common Stock will be subject to a redemption price equal to the greater of (1) the sum of (A) 2.25 times 2.2859 times the Series B Investors Common Stock price, plus (B) any dividends declared but unpaid thereon and (ii) the Series B Investors Common Stock appraised value. The Company had recorded the Series B Common Stock $2.1 million redemption value and the Series A Common Stock $0.8 million value together in mezzanine equity as of December 31, 2014. The Company had recorded the Series B Common Stock $2.1 million redemption value and the Series A Common Stock $0.8 million redemption value together in mezzanine equity as of December 31, 2014. On July 7, 2015, all of the Company's redeemable common stock converted into 113,294 shares of common stock. Warrants On May 2, 2014, the Company issued 131,239 common stock warrants to purchase an aggregate of 131,239 shares of its common stock at an exercise price of $2.95 per share to two entities affiliated with SVB. The common stock warrants were immediately exercisable upon issuance and have a 10 -year term. The fair value of the common stock warrants on the date of issue was approximately $0.2 million which was recorded as an increase to additional paid in capital and as a debt discount. On July 24, 2015, the Company issued an aggregate of 59,281 shares of common stock from the cashless exercise of 65,620 warrants at an exercise price of $2.95 per share for one of the affiliates. On December 22, 2015, the Company issued an aggregate of 54,830 shares of common stock from the cashless exercise of 65,619 warrants at an exercise price of $2.95 per share for one of the affiliates. The Company had no warrants outstanding as of December 31, 2015. Stock Plan and Stock Options The Company’s 2015 Incentive Award Plan (the “Plan”) provides for the issuance of incentive and nonstatutory options and other equity-based awards to its employees and non ‑employees. Options issued under the Plan are exercisable for periods not to exceed ten years, and vest and contain such other terms and conditions as specified in the applicable award document. Prior to becoming a public enterprise, pursuant to the Company’s Second Amended and Restated Stock Incentive Plan which is now retired, the Company historically issued incentive and non-statutory stock options with exercise prices equal to the fair value of the Company’s common stock on the date of grant, as determined by the Company’s board of directors informed by third-party valuations. Subsequent to becoming a public enterprise, only options to buy common stock have been issed under the Plan, with exercise prices equal to the closing price of shares of the Company’s common stock on the New York Stock Exchange on the trading day immediately preceding the date of award. Activity under the Plan is as follows (in thousands, except share and per share amounts and years): Weighted- Weighted- Average Shares Number of Average Remaining Aggregate Available Shares Exercise Contractual Intrinsic for Grant Outstanding Price Life in Years Value Balance at January 1, 2013 $ $ Increase in Plan authorized shares — $ — $ Stock option grants $ $ Stock options exercised — $ $ Stock options cancelled — $ $ Balance at December 31, 2013 $ $ Increase in Plan authorized shares — $ — $ Stock option grants $ $ Stock options exercised — $ $ Stock options cancelled — $ $ Balance at December 31, 2014 $ $ Increase in Plan authorized shares — $ — — $ — Stock option grants $ — — $ — Stock options exercised — $ — — $ — Stock options cancelled $ — — $ — Stock options expired $ — — $ — Balance at December 31, 2015 $ $ Vested or expected to vest December 31, 2015 $ $ Exercisable as of December 31, 2015 $ $ The total grant ‑date fair value of stock options granted during the year ended December 31, 2015, 2014 and 2013 was $ 10.8 million, $4.8 million and $0.7 million, respectively. Stock ‑Based Compensation All stock ‑based awards to employees are measured based on the grant ‑date fair value of the awards and are generally recognized in the Company’s consolidated statement of operations over the period during which the employee is required to perform services in exchange for the award (generally requiring a four ‑year vesting period for each award). The Company estimates the fair value of stock options granted using the Black ‑Scholes option ‑pricing model. Compensation cost is generally recognized over the vesting period of the applicable award using the straight ‑line method. Given the absence of a public trading market prior to July 2015, the Company’s board of directors considered numerous objective and subjective factors to determine the fair value of its common stock at each grant date. These factors included, but were not limited to, (i) contemporaneous valuations of common stock performed by unrelated third ‑party specialists; (ii) the prices for the Preferred Stock sold to outside investors; (iii) the rights, preferences and privileges of the Preferred Stock relative to the common stock; (iv) the lack of marketability of the common stock; (v) developments in the business; and (vi) the likelihood of achieving a liquidity event, such as an IPO or a merger or acquisition of the Company, given prevailing market conditions. The assumptions used in the Black ‑Scholes option ‑pricing model were determined as follows: Volatility. Since the Company does not have a trading history prior to July 2015 for its common stock, the expected volatility was derived from the historical stock volatilities of several unrelated public companies within its industry that it considers to be comparable to its business over a period equivalent to the expected term of the stock option grants. Risk ‑Free Interest Rate. The risk ‑free interest rate is based on U.S. Treasury zero ‑coupon issues with remaining terms similar to the expected term on the options. Expected Term. The expected term represents the period that the stock ‑based awards are expected to be outstanding. When establishing the expected term assumption, the Company used the “simplified” method because the Company does not have adequate historical data. Dividend Yield. The Company has never declared or paid any cash dividends and does not plan to pay cash dividends in the foreseeable future, and therefore, it used an expected dividend yield of zero. Forfeiture rate. The Company uses historical data to estimate pre ‑ vesting option forfeitures and record stock ‑based compensation expense only for those awards that are expected to vest. The fair value of each option grant was estimated on the date of grant using the Black ‑Scholes option ‑pricing model with the following assumptions and fair value per share: Year Ended December 31, 2015 2014 2013 Volatility 45.4% – 51.0% 53.3% – 53.7% 51.0% – 53.4% Expected life (in years) 6.9 7 7 Risk-free interest rate 1.85% - 2.06% 1.92% - 2.30% 1.15% - 2.21% Dividend yield – – – Weighted-average fair value of underlying common stock $ 7.09 $ 5.53 $ 1.07 Total compensation costs charged as an expense for stock ‑based awards, including stock options, recognized in the components of operating expenses are as follows (in thousands): Year Ended December 31, 2015 2014 2013 Administrative and marketing $ $ $ Sales Technology and development General and administrative Total stock-based compensation expense $ $ $ As of December 31, 2015, the Company had $11.2 million in unrecognized compensation cost related to non ‑vested stock options, which is expected to be recognized over a weighted ‑average period of approximately 3.2 years.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2015
Income Taxes
Income Taxes	Note 15. Income Taxes The components of loss from continuing operations before income taxes were generated substantially in the United States as follows (in thousands): Year Ended December 31, 2015 2014 2013 United States $ $ $ As a result of the Company’s history of net operating losses and full valuation allowance against its deferred tax assets, only the timing differences attributable to the treatment of the amortization of tax deductible goodwill generated the income tax provision for the years ended December 31, 2015, 2014 and 2013. In addition for the year ended December 31, 2015 the income tax provision was partially offset by an income tax benefit that was realized as a result of acquisition activity. Reconciliations of the statutory federal income tax rate and the Company’s effective tax rate consist of the following (in thousands): Year Ended December 31, 2015 2014 2013 Tax at federal statutory rate $ $ $ State and local tax Non-deductible stock compensation Non-deductible expenses Change in valuation allowance Income tax provision $ $ $ Significant components of the Company’s deferred tax assets and liabilities were as follows (in thousands): As of December 31, 2015 2014 Deferred tax assets (liabilities): Net operating loss carryforwards $ $ Accrued expenses Stock-based compensation Amortization of intangible assets Depreciation of property and equipment Valuation allowance Other — Net deferred tax assets (liabilities) $ $ The Company has provided a full valuation allowance for its deferred tax assets at December 31, 2015 and 2014, due to the uncertainty surrounding the future realization of such assets. Therefore, no benefit has been recognized for the net operating loss carryforwards and other deferred tax assets. The valuation allowance increased by $24.1 million, $6.7 million and $2.3 million during the years ended December 31, 2015, 2014 and 2013, respectively. For the year ended December 31, 2015, the valuation allowance included an increase of approximately $2.0 million associated with acquisition activity. As of December 31, 2015, the Company had approximately $ 120.0 million of federal and state net operating loss carryforwards available to offset future taxable income. If not utilized, the federal net operating loss carryforwards begin to expire in 2024. The deferred tax asset related to its net operating losses include no excess tax benefit of stock option exercises, which, when realized, will be recorded as a credit to additional paid ‑in capital. The Company’s ability to utilize the net operating loss and tax credit carryforwards in the future may be subject to substantial restrictions in the event of past or future ownership changes as defined in Section 382 of the U.S. Internal Revenue Code of 1986, as amended (the “Internal Revenue Code”). In the event the Company should experience an ownership change, as defined in the Internal Revenue Code, utilization of its net operating loss carryforwards and tax credits could be limited. The Company has previously recorded an uncertain tax position of $2.3 million during the year ended December 31, 2013. There were no additional uncertain tax positions recorded in 2015 and 2014. The Company has recognized $0.1 million of interest expense in both of the years ended December 31, 2015 and 2014 related to unrealized tax benefits. At December 31, 2015 and 2014, the Company had a liability for the payment of interest and penalties of approximately $0.6 million and $0.5 million, respectively, related to unrecognized tax benefits. The Company does not anticipate that the total amounts of unrecognized tax benefits will significantly increase or decrease in the next 12 months. The Company’s tax jurisdiction is the United States. The Company’s 2012 through 2015 tax years are open to examination by U.S. federal and state tax authorities.

Net Loss per Share

Net Loss per Share	12 Months Ended
	Dec. 31, 2015
Net Loss per Share
Net Loss per Share	Note 16. Net Loss per Share Basic net loss per share is computed by dividing the net loss by the weighted ‑average number of shares of common stock of the Company outstanding during the period. Diluted net loss per share is computed by giving effect to all potential shares of common stock of the Company, including the Preferred Stock and outstanding stock options and warrants, to the extent dilutive. Basic and diluted net loss per share was the same for each period presented as the inclusion of all potential shares of common stock of the Company outstanding would have been anti ‑dilutive. The following table presents the calculation of basic and diluted net loss per share for the Company’s common stock (in thousands, except per share data): Year Ended December 31, 2015 2014 2013 Net loss $ $ $ Preferred stock dividends — Accretion of preferred stock — Net loss $ $ $ Weighted-average shares used to compute basic and diluted net loss per share Net loss per share, basic and diluted $ $ $ Unaudited Pro Forma Net Loss per Share The holders of a majority of the outstanding shares of the Preferred Stock (voting as a single class on an as-converted basis, including holders of at least a majority of the outstanding shares of Series F Preferred Stock) approved the automatic conversion of the Preferred Stock into common stock of the Company upon the closing of the IPO. Accordingly on July 7, 2015, all of the Company’s then outstanding preferred stock converted into common stock. Unaudited pro forma basic and diluted net loss per share were computed to give effect to the IPO in which the Company issued and sold 9,487,500 shares of common stock and the conversion of the Preferred Stock into common stock of the Company using the if ‑converted method as though the conversion and reclassification had occurred as of the beginning of the first period presented or the original date of issuance, if later. The following table presents the calculation of basic and diluted unaudited pro forma net loss per share (in thousands, except net loss per share data): Year Ended December 31, 2015 Net loss $ Unaudited pro forma basic and diluted net loss per share $ Unaudited pro forma net loss per share - weighted average shares Basic net loss per share - weighted average shares IPO Preferred conversion Unaudited pro forma net loss per share - weighted average shares

401(k) Plan

401(k) Plan	12 Months Ended
	Dec. 31, 2015
401(k) Plan
401(k) Plan	Note 17. 401(k) Plan The Company has established a 401(k) plan that qualifies as a deferred compensation arrangement under Section 401 of the Internal Revenue Code. All employees over the age of 21 are eligible to participate in the plan. The Company contributes 100% of an employee’s elective deferral up to 4% of eligible earnings up to a maximum of $0.3 million. The Company made matching contributions to participants’ accounts totaling $0. 7 million, $0.4 million and $0.2 million during the years ended December 31, 2015, 2014 and 2013, respectively.

Legal Matters

Legal Matters	12 Months Ended
	Dec. 31, 2015
Legal Matters
Legal Matters	Note 18. Legal Matters The Company may become subject to legal proceedings, claims and litigation arising in the ordinary course of its business. At December 31, 2015, the Company was party to the following legal proceedings: Teladoc is plaintiff in two lawsuits in the Texas courts against the Texas Medical Board (the ‘‘TMB’’). In the first suit, Teladoc v. TMB and Leshikar, on December 31, 2014, the Austin Court of Appeals granted Teladoc’s request for summary judgment, invalidating the TMB’s prior assertion that Teladoc’s doctors do not form ‘‘proper professional relationships’’ with Teladoc’s members in the course of telehealth consultations such as would support the prescription of medications. The TMB has filed a petition for review with the Texas Supreme Court to ask that Court if it will allow the TMB to appeal the Court of Appeals’s decision. This petition is pending. In the second suit, Teladoc et al. v. TMB et al., the United States District Court for the Western District of Texas, Austin Division, held a hearing on May 22, 2015 on Teladoc’s motion for preliminary injunction of the rule amendments the TMB adopted on April 10, 2015 that seek to effect substantively identical restrictions as at issue in the prior lawsuit in state court. On May 29, 2015, the court granted Teladoc’s request for a preliminary injunction of the rule amendments, pending ultimate trial on the amendments’ validity. On July 30, 2015, the TMB filed a motion to dismiss the suit, and the federal court denied this motion on December 14, 2015. On January 8, 2016, the TMB provided notice of its intent to appeal the federal court’s denial of its motion to dismiss to the U.S. Court of Appeals for the Fifth Circuit, which appeal has not yet been filed. On January 14, 2016, the federal court granted the parties’ joint motion to stay the trial case pending the aforementioned appeal. Accordingly, no trial date has been set. Business in the State of Texas accounted for approximately $12.6 million, or 16% , $10.0 million, or 23% and $2.3 million or 12% of Teladoc’s consolidated revenue during the years ended December 31, 2015, 2014 and 2013, respectively. If the TMB’s proposed rule amendments go into effect as written and Teladoc is unable to adapt its business model in compliance with the revised rules, its ability to operate its business in the State of Texas could be materially adversely affected, which would have a material adverse effect on its business, financial condition and results of operations. On June 8, 2015, American Well Corporation filed a complaint against Teladoc in the United States District Court for the District of Massachusetts alleging that certain of its operating platform’s technology infringes one of American Well’s patents, which patent Teladoc is seeking to invalidate pursuant to a petition for inter partes review that Teladoc filed with the U.S. Patent and Trademark Office’s Patent Trial and Appeals Board in March 2015. On November 11, 2015, Teladoc filed a motion to dismiss American Well’s complaint. This motion is pending before the court. Teladoc has investigated the claims alleged in American Well’s complaint and believes that it has good defenses to the claims. However, were Teladoc ultimately not to prevail in the lawsuit, its results of operations could be affected. Other than as stated the Company is not a party to any material legal proceeding, and it is not aware of any pending or threatened litigation that would have a material adverse effect on its business, results of operations, cash flows or financial condition should such litigation be resolved unfavorably.

Summary of Significant Accoun27

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2015
Summary of Significant Accounting Policies
Basis of Presentation and Principles of Consolidation	Basis of Presentation and Principles of Consolidation These consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”). The consolidated financial statements include the results of Teladoc, a professional association and seven professional corporations: Teladoc Physicians, P.A., Teladoc Physicians, P.C. formed and operated in Alaska; Teladoc Physicians, P.C. formed and operated in California; Teladoc Physicians, P.C. formed and operated in Colorado; Teladoc Physicians, P.C. formed and operated in Michigan; Teladoc Physicians, P.C. formed and operated in New Jersey; Teladoc Physicians, P.C. formed and operated in New York; and Teladoc Physicians, P.C. formed and operated in North Carolina (collectively, the “Association”). Teladoc Physicians, P.A. is party to a Services Agreement by and among it and the seven professional corporations noted above pursuant to which each professional corporation provides services to Teladoc Physicians, P.A. Each professional corporation is established pursuant to the requirements of its respective domestic jurisdiction governing the corporate practice of medicine. The Company holds a variable interest in the Association which contracts with physicians and other health professionals in order to provide services to Teladoc. The Association is considered a variable interest entity (“VIE”) since it does not have sufficient equity to finance its activities without additional subordinated financial support. An enterprise having a controlling financial interest in a VIE, must consolidate the VIE if it has both power and benefits—that is, it has (1) the power to direct the activities of a VIE that most significantly impact the VIE’s economic performance (power) and (2) the obligation to absorb losses of the VIE that potentially could be significant to the VIE or the right to receive benefits from the VIE that potentially could be significant to the VIE (benefits). The Company has the power and rights to control all activities of the Association and funds and absorbs all losses of the VIE. Total revenue and net loss for the VIE were $13.9 million and $(7.3) million, $6.5 million and $(3.9) million and $3.3 million and $(1.0) million for the years ended December 31, 2015, 2014 and 2013, respectively. The VIE’s total assets were $2.4 million and $2.1 million at December 31, 2015 and 2014, respectively. Total liabilities for the VIE were $18.7 million and $11.2 million at December 31, 2015 and 2014, respectively. The VIE total stockholders’ deficit was $16.4 million and $9.1 million at December 31, 2015 and 2014, respectively. All significant intercompany transactions and balances have been eliminated.
Business Combinations	Business Combinations The Company accounts for its business combinations using the acquisition method of accounting. The cost of an acquisition is measured as the aggregate of the acquisition date fair values of the assets transferred and liabilities assumed by the Company to the sellers and equity instruments issued. Transaction costs directly attributable to the acquisition are expensed as incurred. Identifiable assets and liabilities acquired or assumed are measured separately at their fair values as of the acquisition date. The excess of (i) the total costs of acquisition over (ii) the fair value of the identifiable net assets of the acquiree is recorded as goodwill.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. The Company bases its estimates on historical experience, current business factors, and various other assumptions that the Company believes are necessary to consider to form a basis for making judgments about the carrying values of assets and liabilities, the recorded amounts of revenue and expenses, and the disclosure of contingent assets and liabilities. The Company is subject to uncertainties such as the impact of future events, economic and political factors, and changes in the Company’s business environment; therefore, actual results could differ from these estimates. Accordingly, the accounting estimates used in the preparation of the Company’s consolidated financial statements will change as new events occur, as more experience is acquired, as additional information is obtained and as the Company’s operating environment evolves. Changes in estimates are made when circumstances warrant. Such changes in estimates and refinements in estimation methodologies are reflected in reported results of operations; if material, the effects of changes in estimates are disclosed in the notes to the consolidated financial statements. Significant estimates and assumptions by management affect the allowance for doubtful accounts, the carrying value of long ‑lived assets (including goodwill and intangible assets), the carrying value, capitalization and amortization of software development costs, client performance guarantees, the calculation of a contingent liability in connection with an earn ‑out, the provision for income taxes and related deferred tax accounts, certain accrued liabilities, revenue recognition, contingencies, litigation and related legal accruals and the value attributed to employee stock options and other stock ‑based awards.
Segment Information	Segment Information The Company’s chief operating decision maker, its Chief Executive Officer (“CEO”), reviews the financial information presented on a consolidated basis for purposes of allocating resources and evaluating its financial performance. Accordingly, the Company has determined that it operates in a single reportable segment—health services.
Revenue Recognition	Revenue Recognition The Company offers two types of subscription access revenue contracts: (i) contracts that provide for a fixed monthly charge for access and unlimited visits per Member and (ii) contracts that provide for a fixed monthly charge for access and a contractually defined cost for each visit. Any visit fee revenue that is not included in the subscription access revenue is recognized when the service has been provided to the Member. The Company recognizes a substantial portion of its revenue from contracts that provide employers and health plans (“Clients”) with subscription access to the Company’s network of physicians and other healthcare professionals (“Providers”) on a subscription basis for a fixed monthly fee which entitles the Client’s employees and their beneficiaries (“Members”) to unlimited consultations (“visits”). The contracts are generally for a one ‑year term and have an automatic renewal feature for additional years. The Company commences revenue recognition for the subscription access service on the date that the services are made available to the Client and its Members, which is considered the implementation date, provided all of the following criteria are met: · there is an executed subscription agreement; · the Member has access to the service; · collection of the fees is reasonably assured; and · the amount of fees to be paid by the Client and Member is fixed and determinable. Subscription Access Revenue Subscription access revenue recognition commences on the date that the Company’s services are made available to the Client, which is considered the implementation date, provided all of the other criteria described above are met. Revenue is recognized over the term of the Client contract and is based on the terms in the Client contracts, which can provide for a variable periodic fee based upon the actual number of Members. Revenue From Visit Fees Revenue from visits is comprised of all revenue that is earned in connection with the completion of a visit. The Company recognizes revenue as the visits are completed. The Company’s contracts do not generally contain refund provisions for fees earned related to services performed. However, certain of the Company’s contracts include client performance guarantees that are based upon minimum Member utilization and guarantees by the Company for specific service level performance of the Company’s services. If client performance guarantees are not being realized, the Company deducts from revenue an estimate of the amount that will be due at the end of the respective client’s contractual period. The Company issued credits amounting to approximately $0.4 million for both of the years ended December 31, 2015 and 2014 and $0.2 million for the year ended December 31, 2013.
Cost of Revenue	Cost of Revenue Cost of revenue primarily consists of fees paid to the Providers, costs incurred in connection with the Company’s Provider network operations, which include employee ‑related expenses (including salaries and benefits) as well as costs related to the Company’s call center and medical malpractice insurance.
Cash and Cash Equivalents	Cash and Cash Equivalents Cash and cash equivalents consist of highly liquid investments with original maturities of three months or less from the date of purchase. The Company’s cash and cash equivalents generally consist of investments in money market funds. Cash and cash equivalents are stated at fair value.
Short-Term Investments	Short-Term Investments The Company holds short-term investments in marketable securities primarily consisting of corporate bonds, commercial paper and asset backed securities with maturities of less than one year. These short-term investments are classified as available-for-sale and are carried at fair value with unrealized gains or losses recorded as a separate component of stockholders’ equity (deficit) in accumulated other comprehensive loss. Realized gains or losses are recognized in the consolidated statements of operations upon disposition of the securities. As of December 31, 2015, there were no short-term investments that had been in a continuous loss position for more than 12 months. Actual maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. Realized gains for the year ended December 31, 2015 were less than $0.1 million and are included in interest income (expense), net in the Company’s consolidated statements of operations. There were no realized losses in 2015, 2014 and 2013.
Accounts Receivable and Allowance for Doubtful Accounts	Accounts Receivable and Allowance for Doubtful Accounts Accounts receivable are recorded at the invoiced amount, net of allowances for doubtful accounts. The allowance for doubtful accounts is based on the Company’s assessment of the collectability of accounts. The Company regularly reviews the adequacy of the allowance for doubtful accounts by considering the age of each outstanding invoice and the collection history of each customer to determine whether a specific allowance is appropriate. Accounts receivable deemed uncollectable are charged against the allowance for doubtful accounts when identified.
Property and Equipment	Property and Equipment Property and equipment are stated at cost less accumulated depreciation. Depreciation is recorded using the straight ‑line method over the estimated useful lives of the respective asset as follows: Computer equipment 3 years Furniture and equipment 5 years Leasehold improvements Shorter of the lease term or the estimated useful lives of the improvements Maintenance and repairs are charged to expense as incurred, and improvements are capitalized. When assets are retired or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gain or loss is reflected in the consolidated statement of operations in the period realized.
Internal-Use Software	Internal ‑Use Software Internal ‑use software is included in intangible assets and is amortized on a straight ‑line basis over 3 years. For the Company’s development costs related to its software development tools that enable its Members and Providers to interact, the Company capitalizes costs incurred during the application development stage. Costs related to minor upgrades, minor enhancements and maintenance activities are expensed as incurred.
Goodwill and Intangible Assets	Goodwill and Intangible Assets Goodwill represents the excess of the purchase price over the fair value of the net tangible and intangible assets acquired in a business combination. Goodwill is not amortized, but is tested for impairment annually on October 1 or more frequently if events or changes in circumstances indicate that the asset may be impaired. The Company’s impairment tests are based on a single operating segment and reporting unit structure. The goodwill impairment test involves a two ‑ step process. The first step involves comparing the fair value of the Company’s reporting unit to its carrying value, including goodwill. The fair value of the reporting unit is estimated using a discounted cash flows analysis. If the carrying value of the reporting unit exceeds its fair value, the second step of the test is performed by comparing the carrying value of the goodwill in the reporting unit to its implied fair value. An impairment charge is recognized for the excess of the carrying value of goodwill over its implied fair value. The Company’s annual goodwill impairment test resulted in no impairment charges in any of the periods presented in the consolidated financial statements. Other intangible assets resulted from business acquisitions and include Client relationships, non ‑compete agreements and trademarks. Client relationships are amortized over a period of 2 to 10 years in relation to expected future cash flows, while non ‑compete agreements are amortized over a period of 3 to 5 years using the straight ‑line method. Trademarks are amortized over 3 years using the straight-line method. Long-lived assets (property and equipment, internally developed software, and intangible assets) used in operations are reviewed for impairment whenever events or changes in circumstances indicate that carrying amounts may not be recoverable. For long-lived assets to be held and used, the Company recognizes an impairment loss only if its carrying amount is not recoverable through its undiscounted cash flows and measures the impairment loss based on the difference between the carrying amount and fair value. In 2015 the Company impaired certain internally developed software as it is no longer being utilized. The impairment loss of $0.8 million is included in general and administrative expense in the consolidated statements of operations. There were no impairment losses in 2014 or 2013.
Stock-Based Compensation	Stock ‑Based Compensation Stock ‑based compensation is measured based on the grant ‑ date fair value of the awards and recognized on a straight ‑line basis over the period during which the employee is required to perform services in exchange for the award (generally the vesting period of the award). The Company estimates the fair value of employee stock options using the Black ‑Scholes option ‑pricing model.
Income Taxes	Income Taxes The Company accounts for income taxes using the liability method, under which deferred tax assets and liabilities are determined based on the future tax consequences attributable to differences between the financial reporting carrying amounts of existing assets and liabilities and their respective tax bases and tax credit carry forwards and net operating loss carryforwards. Deferred tax assets and liabilities are measured using the enacted tax rates that are expected to be in effect when the differences are expected to reverse. The Company assesses the likelihood that deferred tax assets will be recovered from future taxable income, and a valuation allowance is established when necessary to reduce deferred tax assets to the amounts more likely than not expected to be realized. The Company recognizes and measures uncertain tax positions using a two ‑ step approach. The first step is to evaluate the tax position taken or expected to be taken by determining if the weight of available evidence indicates that it is more likely than not that the tax position will be sustained in an audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% likely to be realized upon ultimate settlement. Significant judgment is required to evaluate uncertain tax positions. The Company evaluates its uncertain tax positions on a regular basis. Its evaluations are based on a number of factors, including changes in facts and circumstances, changes in tax law, correspondence with tax authorities during the course of audit and effective settlement of audit issues. The Company’s policy is to include interest and penalties related to unrecognized tax benefits as a component of interest income (expense), net in the consolidated statements of operations.
Comprehensive Loss	Comprehensive Loss Comprehensive loss consists of net loss and unrealized gains or losses on short-term investments. Unrealized gains or losses are net of any reclassification adjustments for realized gains and losses included in the consolidated statements of operations.
Warranties and Indemnification	Warranties and Indemnification The Company’s arrangements generally include certain provisions for indemnifying Clients against liabilities if there is a breach of a Client’s data or if the Company’s service infringes a third party’s intellectual property rights. To date, the Company has not incurred any material costs as a result of such indemnifications. The Company has also agreed to indemnify its directors and executive officers for costs associated with any fees, expenses, judgments, fines and settlement amounts incurred by any of these persons in any action or proceeding to which any of those persons is, or is threatened to be, made a party by reason of the person’s service as a director or officer, including any action by the Company, arising out of that person’s services as a director or officer or that person’s services provided to any other company or enterprise at the Company’s request. The Company maintains director and officer liability insurance coverage that would generally enable it to recover a portion of any future amounts paid. The Company may also be subject to indemnification obligations by law with respect to the actions of its employees under certain circumstances and in certain jurisdictions.
Advertising and Marketing Expenses	Advertising and Marketing Expenses Advertising and marketing include all communications and campaigns to the Company’s Clients and Members and related employees’ costs and are expensed as incurred. For the years ended December 31, 2015, 2014 and 2013, advertising expenses were $17.3 million, $6.0 million and $3.0 million, respectively.
Concentrations of Risk and Significant Clients	Concentrations of Risk and Significant Clients The Company’s financial instruments that are exposed to concentrations of credit risk consist primarily of cash and cash equivalents, and accounts receivable. Although the Company deposits its cash with multiple financial institutions, its deposits, at times, may exceed federally insured limits.
Reclassifications	During the year ended December 31, 2015, substantially all of the Company’s revenue was generated by Clients located in the United States. During the year ended 2014 and 2013, all of the Company’s revenue was generated by clients located in the United States. No Client represented over 10% of accounts receivable for the years ended December 31, 2015 and 2014 or revenues for the years ended December 31, 2015, 2014 and 2013. Reclassifications Certain prior year amounts have been reclassified to conform to the current year presentation.
Seasonality	Seasonality The Company typically experiences the strongest increases in consecutive quarterly revenue during the fourth and first quarters of each year, which coincides with traditional annual benefit enrollment seasons. In particular, as a result of many Clients’ introduction of new services at the very end of a calendar year, or the start of each calendar year, the majority of the Company’s new Client contracts have an effective date of January 1. Additionally, as a result of national seasonal cold and flu trends, the Company experiences the highest level of visit fees during the first and fourth quarters of each year when compared to other quarters of the year. Conversely, the second quarter of the year has historically been the period of lowest utilization of the Company’s Provider network services relative to the other quarters of the year.
Recently Issued and Adopted Accounting Pronouncements	Recently Issued and Adopted Accounting Pronouncements In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (Topic 606), to achieve a consistent application of revenue recognition within the U.S., resulting in a single revenue model to be applied by reporting companies under GAAP. Under the new model, recognition of revenue occurs when a customer obtains control of promised goods or services in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In addition, the revised guidance requires that reporting companies disclose the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. The revised guidance is effective for the Company beginning in the quarter ending March 31, 2018; early adoption is allowed. The revised guidance is required to be applied retrospectively to each prior reporting period presented or retrospectively with the cumulative effect of initially applying it recognized at the date of initial application. The Company is currently evaluating the transition method that will be elected and the potential effect of the revised guidance will have on the Company’s consolidated financial statements. In June 2014, the FASB issued ASU 2014-12, Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period , requiring that a performance target that affects vesting and that could be achieved after the requisite service period be treated as a performance condition. The amendments in this guidance are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. The Company is currently evaluating the potential impact of this guidance on the Company’s financial disclosures and results. In August 2014, the FASB issued ASU 2014-15, Presentation of Financial Statements—Going Concern . This guidance addresses management’s responsibility to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern and to provide related footnote disclosures. Management’s evaluation should be based on relevant conditions and events that are known and reasonably knowable at the date that the financial statements are issued. ASU 2014-15 is effective for interim or annual periods beginning after December 15, 2016. Early adoption is permitted. The Company does not expect to early adopt this guidance and is currently evaluating the impact of the adoption of this guidance on the Company’s financial disclosures and results. In April 2015, the FASB issued ASU 2015-03, Interest—Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs, which requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The revised guidance is effective for the Company beginning in the quarter ending March 31, 2016 and is required to be applied retrospectively. Early adoption is permitted. The Company has early adopted ASU 2015-03 which resulted in a $0.1 million and $0.2 million balance sheet reclassification as of December 31, 2015 and 2014, respectively. In September 2015, the FASB issued ASU 2015-16, Business Combinations - Simplifying the Accounting for Measurement-Period Adjustments (Topic 805). ASU 2015-16 requires that an acquirer recognize adjustments to provisional amounts that are identified during the measurement period in the reporting period in which the adjustment amounts are determined. ASU 2015-16 is effective for interim and annual periods beginning after December 15, 2015, with early adoption permitted, and is to be applied on a prospective basis. The Company is currently in the process of evaluating the impact of the adoption of this standard on the Company’s consolidated financial statements. In November 2015, the FASB issued ASU 2015-17, Income Taxes (Topic 740): Balance Sheet Classification of Deferred Taxes . ASU 2015-17 simplifies the presentation of deferred income taxes by eliminating the separate classification of deferred income tax liabilities and assets into current and noncurrent amounts in the consolidated balance sheet. The amendments in the update require that all deferred tax liabilities and assets be classified as noncurrent in the consolidated balance sheet. The amendments in this update are effective for annual periods beginning after December 15, 2016, and interim periods therein and may be applied either prospectively or retrospectively to all periods presented. Early adoption is permitted. The Company has early adopted this standard in the fourth quarter of 2015 on a retrospective basis. Prior periods have been retrospectively adjusted. As a result of the adoption of ASU 2015-17, the Company reclassified $12,000 between current deferred tax assets and n oncurrent deferred tax liabilities in the 2014 balance sheet . In January 2016, the FASB issued ASU 2016-01, Financial Instruments-Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities . ASU 2016-01 amends various aspects of the recognition, measurement, presentation, and disclosure for financial instruments. With respect to our consolidated financial statements, the most significant impact relates to the accounting for equity investments. It will impact the disclosure and presentation of financial assets and liabilities. ASU 2016-01 is effective for annual reporting periods, and interim periods within those years beginning after December 15, 2017. Early adoption by public entities is permitted only for certain provisions. The Company is currently in the process of evaluating the impact of the adoption of this standard on the Company’s consolidated financial statements.

Summary of Significant Accoun28

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2015
Summary of Significant Accounting Policies
Summary of useful life of property and equipment	Property and equipment are stated at cost less accumulated depreciation. Depreciation is recorded using the straight ‑line method over the estimated useful lives of the respective asset as follows: Computer equipment 3 years Furniture and equipment 5 years Leasehold improvements Shorter of the lease term or the estimated useful lives of the improvements

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	12 Months Ended
	Dec. 31, 2015
Fair Value Measurements
Schedule assets and liabilities measured at fair value on a recurring basis	The following tables present information about the Company’s assets and liabilities that are measured at fair value on a recurring basis using the above input categories (in thousands): December 31, 2015 Level 1 Level 2 Level 3 Total Cash and cash equivalents $ $ — $ — $ Short-term investments $ — $ $ — $ Contingent liability (included in accrued expenses and other current liabilities and other liabilities) $ — $ — $ $ December 31, 2014 Level 1 Level 2 Level 3 Total Cash and cash equivalents $ $ — $ — $
Schedule of reconciliation of company's Level 3 liabilities	Fair value at date of acquisition $ Payments earned Change in fair value Fair value at December 31, 2015 $

Lease Abandonment Charge (Table

Lease Abandonment Charge (Tables)	12 Months Ended
	Dec. 31, 2015
Lease Abandonment Charge
Schedule of lease abandonment charges	The following table details the associated liability. The current portion of the liability of $0.4 million was recorded in accrued expenses and other current liabilities and the non-current portion of the liability of $0.1 million was recorded in other liabilities in the consolidated balance sheet (in thousands): Balance January 1, 2015 $ — Charged to expense Paid or settled Balance December 31, 2015 $

Business Acquisitions (Tables)

Business Acquisitions (Tables)	12 Months Ended
	Dec. 31, 2015
Business Acquisitions
Summary of identifiable assets acquired and liabilities assumed	Identifiable assets acquired and liabilities assumed (in thousands): StatDoc BetterHelp AmeriDoc CADR Purchase price $ $ $ $ Less: Cash Accounts receivable Other assets Client relationships Non-compete agreements Internal software — — Trademarks — — — Accounts payable Deferred tax — — Other liabilities — Goodwill $ $ $ $
Schedule of unaudited pro forma revenue and net loss	Unaudited Pro Forma (in thousands) 2015 2014 Revenue $ $ Net loss $ $

Property and Equipment, Net (Ta

Property and Equipment, Net (Tables)	12 Months Ended
	Dec. 31, 2015
Property and Equipment, Net
Summary of property and equipment, net	Property and equipment, net, consist of the following (in thousands): As of December 31, 2015 2014 Computer equipment $ $ Furniture and equipment Leasehold improvement — Construction in progress — Total Accumulated depreciation Property and equipment, net $ $

Intangible Assets, Net (Tables)

Intangible Assets, Net (Tables)	12 Months Ended
	Dec. 31, 2015
Intangible Assets, Net
Schedule of finite lived intangible assets	Intangible assets consist of the following (in thousands): Weighted Average Useful Accumulated Net Carrying Remaining Life Gross Value Amortization Value Useful Life December 31, 2015 Client relationships 2 to 10 years $ $ $ Non-compete agreements 3 to 5 years Trademarks 3 years Internal software 3 years Intangible assets, net $ $ $ December 31, 2014 Client relationships 10 years $ $ $ Non-compete agreements 3 to 5 years Internal software 3 years Intangible assets, net $ $ $
Schedule of amortization to be charged to expense over the remaining life of the intangible assets	Periodic amortization that will be charged to expense over the remaining life of the intangible assets as of December 31, 2015 is as follows (in thousands): Years Ending December 31, 2016 $ 2017 2018 2019 2020 Thereafter $

Goodwill (Tables)

Goodwill (Tables)	12 Months Ended
	Dec. 31, 2015
Goodwill
Summary of goodwill	Goodwill consists of the following (in thousands): As of December 31, 2015 2014 Beginning balance $ $ Additions associated with acquisitions Goodwill $ $

Accrued Expenses and Other Cu35

Accrued Expenses and Other Current Liabilities (Tables)	12 Months Ended
	Dec. 31, 2015
Accrued Expenses and Other Current Liabilities
Schedule of accrued expenses and other current liabilities	Accrued expenses and other current liabilities consist of the following (in thousands): As of December 31, 2015 2014 Professional fees $ $ Consulting fees/cutomer service fees/provider fees Legal fees Interest payable Earnout and compensation — Lease abandonment — Deferred revenue — Other Total $ $

Long Term Bank and Other Debt (

Long Term Bank and Other Debt (Tables)	12 Months Ended
	Dec. 31, 2015
Long Term Bank and Other Debt
Schedule of long-term bank and other debt components	Long ‑term bank and other debt consist of the following (in thousands): As of December 31, 2015 2014 SVB Mezzanine Term Loan less debt discount of $190 and $327 $ $ SVB Term Loan Facility SVB Revolving Advance Facility Subordinated Promissory Note Total Less: current portion of SVB Term Loan Facility Long term bank and other debt $ $
Schedule of payments due for long-term debt	Payments due are as follows (in thousands): Total 2016 $ 2017 2018 2019 2020 and thereafter — Total $

Leases and Contractual Obliga37

Leases and Contractual Obligations (Tables)	12 Months Ended
	Dec. 31, 2015
Leases and Contractual Obligations
Schedule of the future minimum lease payments under non cancelable operating leases	As of December 31, 2015, the future minimum lease payments under non ‑cancelable operating leases are as follows (in thousands): Operating Leases 2016 $ 2017 2018 2019 2020 2021 and thereafter $

Convertible Preferred Stock (38

Convertible Preferred Stock (the "Preferred Stock") (Tables)	12 Months Ended
	Dec. 31, 2015
Convertible Preferred Stock (the "Preferred Stock")
Schedule of Preferred Stock outstanding	Common Shares Shares Shares Upon Liquidation December 31, 2014 Authorized Outstanding Conversion Preference Series A $ Series A-1 Series B Series C-1 Series D Series E Series F $
Schedule of conversion rights of Preferred Stock	Number of Shares of Common Stock Issued for each Preferred Share Upon Conversion Original Conversion (= Original Issue Price/ Series of Preferred Stock Issue Price Price Conversion Price) Series F $ $ Series E $ $ Series D $ $ Series C-1 $ $ Series B $ $ Series A-1 $ $ Series A $ $

Common Stock and Stockholders39

Common Stock and Stockholders’ Equity (Deficit) (Tables)	12 Months Ended
	Dec. 31, 2015
Common Stock and Stockholders’ Equity (Deficit)
Summary of activity under the Plan	Activity under the Plan is as follows (in thousands, except share and per share amounts and years): Weighted- Weighted- Average Shares Number of Average Remaining Aggregate Available Shares Exercise Contractual Intrinsic for Grant Outstanding Price Life in Years Value Balance at January 1, 2013 $ $ Increase in Plan authorized shares — $ — $ Stock option grants $ $ Stock options exercised — $ $ Stock options cancelled — $ $ Balance at December 31, 2013 $ $ Increase in Plan authorized shares — $ — $ Stock option grants $ $ Stock options exercised — $ $ Stock options cancelled — $ $ Balance at December 31, 2014 $ $ Increase in Plan authorized shares — $ — — $ — Stock option grants $ — — $ — Stock options exercised — $ — — $ — Stock options cancelled $ — — $ — Stock options expired $ — — $ — Balance at December 31, 2015 $ $ Vested or expected to vest December 31, 2015 $ $ Exercisable as of December 31, 2015 $ $
Assumptions used for estimate of fair value of options	Year Ended December 31, 2015 2014 2013 Volatility 45.4% – 51.0% 53.3% – 53.7% 51.0% – 53.4% Expected life (in years) 6.9 7 7 Risk-free interest rate 1.85% - 2.06% 1.92% - 2.30% 1.15% - 2.21% Dividend yield – – – Weighted-average fair value of underlying common stock $ 7.09 $ 5.53 $ 1.07
Components of operating expense charged for compensation cost expense	Total compensation costs charged as an expense for stock ‑based awards, including stock options, recognized in the components of operating expenses are as follows (in thousands): Year Ended December 31, 2015 2014 2013 Administrative and marketing $ $ $ Sales Technology and development General and administrative Total stock-based compensation expense $ $ $

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2015
Income Taxes
Schedule of components of loss from continuing operations before income taxes	The components of loss from continuing operations before income taxes were generated substantially in the United States as follows (in thousands): Year Ended December 31, 2015 2014 2013 United States $ $ $
Schedule of reconciliations of the statutory federal income tax rate to the effective income tax rate	Reconciliations of the statutory federal income tax rate and the Company’s effective tax rate consist of the following (in thousands): Year Ended December 31, 2015 2014 2013 Tax at federal statutory rate $ $ $ State and local tax Non-deductible stock compensation Non-deductible expenses Change in valuation allowance Income tax provision $ $ $
Schedule of significant components of deferred tax assets and liabilities	Significant components of the Company’s deferred tax assets and liabilities were as follows (in thousands): As of December 31, 2015 2014 Deferred tax assets (liabilities): Net operating loss carryforwards $ $ Accrued expenses Stock-based compensation Amortization of intangible assets Depreciation of property and equipment Valuation allowance Other — Net deferred tax assets (liabilities) $ $

Net Loss per Share (Tables)

Net Loss per Share (Tables)	12 Months Ended
	Dec. 31, 2015
Net Loss per Share
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	The following table presents the calculation of basic and diluted net loss per share for the Company’s common stock (in thousands, except per share data): Year Ended December 31, 2015 2014 2013 Net loss $ $ $ Preferred stock dividends — Accretion of preferred stock — Net loss $ $ $ Weighted-average shares used to compute basic and diluted net loss per share Net loss per share, basic and diluted $ $ $
Schedule of calculation of basic and diluted pro forma net loss per share	The following table presents the calculation of basic and diluted unaudited pro forma net loss per share (in thousands, except net loss per share data): Year Ended December 31, 2015 Net loss $ Unaudited pro forma basic and diluted net loss per share $ Unaudited pro forma net loss per share - weighted average shares Basic net loss per share - weighted average shares IPO Preferred conversion Unaudited pro forma net loss per share - weighted average shares

Organization and Description 42

Organization and Description of Business (Details) $ / shares in Units, $ in Millions	Jul. 07, 2015USD ($)$ / sharesshares	Jun. 17, 2015USD ($)$ / sharesshares	Dec. 31, 2015item$ / shares	Dec. 31, 2014$ / shares	Dec. 31, 2013$ / shares
Organization and Description of Business
Number of acquisitions | item			3
Initial Public Offering
Issuance of stock under IPO (in shares)	9,487,500
Price of stock issued (in dollars per share) | $ / shares			$ 7.09	$ 5.53	$ 1.07
Number of shares issued upon conversion of convertible stock	25.5
Convertible Preferred Stock
Initial Public Offering
Number of shares issued upon conversion of convertible stock	25,500,000	25,500,000
Redeemable Common Stock
Initial Public Offering
Number of shares issued upon conversion of convertible stock	113,294	113,294
IPO And Over-Allotment Option
Initial Public Offering
Issuance of stock under IPO (in shares)	9,487,500	9,487,500
Price of stock issued (in dollars per share) | $ / shares	$ 19	$ 19
Proceeds received, net of issuance costs | $	$ 163.1	$ 163.1
Underwriting discounts and commissions | $	12.6	12.6
Other offering expenses | $	$ 4.5	$ 4.5

Summary of Significant Accoun43

Summary of Significant Accounting Policies - VIE (Details) $ in Millions	12 Months Ended
	Dec. 31, 2015USD ($)item	Dec. 31, 2014USD ($)	Dec. 31, 2013USD ($)
Variable interest entity
Number of professional corporations consolidated as VIEs | item	7
Primary beneficiary
Variable interest entity
Total revenue of VIEs	$ 13.9	$ 6.5	$ 3.3
Net loss of VIEs	(7.3)	(3.9)	$ (1)
Assets of VIEs	2.4	2.1
Liabilities of VIEs	18.7	11.2
Deficit of VIEs	$ 16.4	$ 9.1

Summary of Significant Accoun44

Summary of Significant Accounting Policies - Revenue Recognition and PPE (Details) $ in Millions	12 Months Ended
	Dec. 31, 2015USD ($)item	Dec. 31, 2014USD ($)	Dec. 31, 2013USD ($)
Revenue recognition
Number of types of subscription access revenue contracts offered | item	2
Contract term	1 year
Credits issued | $	$ 0.4	$ 0.4	$ 0.2
Computer equipment
Property and Equipment
Useful life	3 years
Furniture and equipment
Property and Equipment
Useful life	5 years

Summary of Significant Accoun45

Summary of Significant Accounting Policies - Investments (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Short term investments, continuous loss position for more than 12 months	$ 0
Realized losses	0	$ 0	$ 0
Interest income (expense), net | Maximum
Realized gains	$ 100

Summary of Significant Accoun46

Summary of Significant Accounting Policies - Intangibles (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Intangible assets
Goodwill impairment charges	$ 0
Impairment loss	798
General and administrative expenses
Intangible assets
Impairment loss	$ 800	$ 0	$ 0
Internal software
Intangible assets
Useful life	3 years	3 years
Client relationships
Intangible assets
Useful life		10 years
Client relationships | Minimum
Intangible assets
Useful life	2 years
Client relationships | Maximum
Intangible assets
Useful life	10 years
Non-compete agreements | Minimum
Intangible assets
Useful life	3 years	3 years
Non-compete agreements | Maximum
Intangible assets
Useful life	5 years	5 years
Trademarks
Intangible assets
Useful life	3 years

Summary of Significant Accoun47

Summary of Significant Accounting Policies - Advertising and Marketing Expenses (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Summary of Significant Accounting Policies
Advertising expense	$ 17.3	$ 6	$ 3

Summary of Significant Accoun48

Summary of Significant Accounting Policies - Recent Accounting Pronouncements (Details) - USD ($)	Dec. 31, 2015	Dec. 31, 2014
New Accounting Pronouncements or Change in Accounting Principle
Intangible assets, net	$ 15,265,000	$ 7,530,000
Long term bank and other debt	25,227,000	25,040,000
Noncurrent deferred tax liability	1,185,000	482,000
Accounting Standards Update 2015-03 | Adjustments for New Accounting Principle, Early Adoption
New Accounting Pronouncements or Change in Accounting Principle
Long term bank and other debt	$ (100,000)	(200,000)
Accounting Standards Update 2015-17 | Adjustments for New Accounting Principle, Early Adoption
New Accounting Pronouncements or Change in Accounting Principle
Current deferred tax assets		(12,000)
Noncurrent deferred tax liability		$ 12,000

Fair Value Measurements - Recur

Fair Value Measurements - Recurring (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Fair Value, Net Asset (Liability)
Fair Value, Assets, Level 1 to Level 2 Transfers, Amount	$ 0	$ 0
Fair Value, Assets, Level 2 to Level 1 Transfers, Amount	0	0
Fair Value, Liabilities, Level 1 to Level 2 Transfers, Amount	0	0
Fair Value, Liabilities, Level 2 to Level 1 Transfers, Amount	0	0
Fair value assets level 3 net transfers	0	0
Fair value liabilities level 3 net transfers	0	0
Recurring
Fair Value, Net Asset (Liability)
Cash and cash equivalents	55,066	46,436
Short-term investments	82,282
Contingent liability (included in accrued expenses and other current liabilities and other liabilities)	3,408
Level 1 | Recurring
Fair Value, Net Asset (Liability)
Cash and cash equivalents	55,066	$ 46,436
Level 2 | Recurring
Fair Value, Net Asset (Liability)
Short-term investments	82,282
Level 3 | Recurring
Fair Value, Net Asset (Liability)
Contingent liability (included in accrued expenses and other current liabilities and other liabilities)	$ 3,408

Fair Value Measurements - Level

Fair Value Measurements - Level 3 (Details) - Contingent Liability $ in Thousands	12 Months Ended
	Dec. 31, 2015USD ($)
Reconciliation of Level 3 liabilities
Fair value at date of acquisition	$ 2,391
Payments earned	(1,080)
Change in fair value	2,097
Fair value at end of year	$ 3,408

Lease Abandonment Charge (Detai

Lease Abandonment Charge (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Lease Abandonment Charge
Current restructuring charges	$ 433
Lease abandonment
Lease Abandonment Charge
Charged to expense	740
Paid or settled	(266)
Balance at end of year	474
Lease abandonment | Accrued expenses and other current liabilities
Lease Abandonment Charge
Current restructuring charges	400
Lease abandonment | Other noncurrent liabilities
Lease Abandonment Charge
Noncurrent restructuring charges	100
Lease abandonment | General and administrative expenses
Lease Abandonment Charge
Charged to expense	$ 800	$ 0	$ 0

Business Acquisitions (Details)

Business Acquisitions (Details) - USD ($) $ in Thousands	Jul. 31, 2015	Jun. 17, 2015	Jan. 23, 2015	May. 01, 2014	Aug. 29, 2013	Sep. 30, 2015	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Less:
Goodwill							$ 56,342	$ 28,454	$ 14,786
Pro forma information
Revenue							79,208	48,924
Net loss							(61,060)	$ (23,575)
Gateway to Provider Access, Inc.
Business acquisition
Purchase price	$ 1,500
Transaction costs associated with acquisition	100
Gateway to Provider Access, Inc. | Maximum
Business acquisition
Adjustments for working capital	$ 100
AmeriDoc
Business acquisition
Percentage of ownership interest acquired (as a percent)				100.00%
Purchase price				$ 17,200
Promissory note				3,500
Adjustments for working capital				200
Identifiable assets acquired and liabilities assumed:
Purchase price							17,214
Less:
Cash							57
Accounts receivable							458
Other assets							18
Accounts payable							(43)
Other liabilities							(257)
Goodwill							13,481
AmeriDoc | General and administrative expenses
Business acquisition
Transaction costs associated with acquisition				$ 200
AmeriDoc | Client relationships
Less:
Finite-lived intangibles							2,980
AmeriDoc | Non-compete agreements
Less:
Finite-lived intangibles							520
BetterHelp
Business acquisition
Purchase price			$ 3,300
Period of earn-out payments (in years)			4 years
Contingent future earn-out payments			$ 2,400
Issuance of unsecured subordinated promissory note			$ 1,000
Promissory note interest rate (as a percent)			5.00%
Identifiable assets acquired and liabilities assumed:
Purchase price							5,749
Less:
Cash							89
Accounts receivable							11
Other assets							4
Accounts payable							(6)
Deferred tax							(666)
Other liabilities							(340)
Goodwill							4,686
BetterHelp | General and administrative expenses
Business acquisition
Transaction costs associated with acquisition			$ 100
BetterHelp | Client relationships
Less:
Finite-lived intangibles							141
BetterHelp | Non-compete agreements
Less:
Finite-lived intangibles							910
BetterHelp | Internal-Use Software
Less:
Finite-lived intangibles							780
BetterHelp | Trademarks
Less:
Finite-lived intangibles							140
StatDoc
Business acquisition
Purchase price		$ 30,100
Cash paid for acquisition		13,300
Equity consideration		$ 16,800
Equity consideration (in shares)		1,051,033
Transaction costs associated with acquisition						$ 300
Identifiable assets acquired and liabilities assumed:
Purchase price							29,991
Less:
Cash							360
Accounts receivable							419
Other assets							70
Accounts payable							(609)
Other liabilities							(701)
Goodwill							23,202
StatDoc | Maximum
Business acquisition
Adjustments for working capital						$ 100
StatDoc | Client relationships
Less:
Finite-lived intangibles							3,220
StatDoc | Non-compete agreements
Less:
Finite-lived intangibles							1,070
StatDoc | Internal-Use Software
Less:
Finite-lived intangibles							2,960
CADR
Business acquisition
Percentage of ownership interest acquired (as a percent)					100.00%
Purchase price					$ 16,600
Adjustments for working capital					200
Identifiable assets acquired and liabilities assumed:
Purchase price							17,187
Less:
Cash							538
Accounts receivable							558
Other assets							37
Accounts payable							(934)
Deferred tax							(2,705)
Goodwill							14,973
CADR | General and administrative expenses
Business acquisition
Transaction costs associated with acquisition					$ 200
CADR | Client relationships
Less:
Finite-lived intangibles							3,810
CADR | Non-compete agreements
Less:
Finite-lived intangibles							$ 910

Property and Equipment, Net (De

Property and Equipment, Net (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Total	$ 8,303	$ 2,327
Accumulated depreciation	(2,044)	(1,262)
Property and equipment, net	6,259	1,065
Depreciation	1,100	300	$ 200
Computer equipment
Total	5,394	1,959
Furniture and equipment
Total	377	$ 368
Leasehold improvement
Total	1,747
Construction in progress
Total	$ 785

Intangible Assets, Net - Summar

Intangible Assets, Net - Summary (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Intangible assets
Gross Value	$ 20,863	$ 10,105
Accumulated Amortization	(5,598)	(2,575)
Net Carrying Value	$ 15,265	$ 7,530
Weighted Average Remaining Useful Life	5 years 10 months 24 days	6 years 9 months 18 days
Amortization expense for intangible assets	$ 3,700	$ 2,000	$ 600
Impairment of long-lived assets	798
Client relationships
Intangible assets
Gross Value	11,651	6,790
Accumulated Amortization	(3,219)	(1,565)
Net Carrying Value	$ 8,432	$ 5,225
Useful life		10 years
Weighted Average Remaining Useful Life	7 years 10 months 24 days	8 years 6 months
Client relationships | Minimum
Intangible assets
Useful life	2 years
Client relationships | Maximum
Intangible assets
Useful life	10 years
Non-compete agreements
Intangible assets
Gross Value	$ 3,410	$ 1,430
Accumulated Amortization	(1,360)	(474)
Net Carrying Value	$ 2,050	$ 956
Weighted Average Remaining Useful Life	2 years 3 months 18 days	2 years 10 months 24 days
Non-compete agreements | Minimum
Intangible assets
Useful life	3 years	3 years
Non-compete agreements | Maximum
Intangible assets
Useful life	5 years	5 years
Trademarks
Intangible assets
Gross Value	$ 140
Accumulated Amortization	(44)
Net Carrying Value	$ 96
Useful life	3 years
Weighted Average Remaining Useful Life	2 years 1 month 6 days
Internal software
Intangible assets
Gross Value	$ 5,662	$ 1,885
Accumulated Amortization	(975)	(536)
Net Carrying Value	$ 4,687	$ 1,349
Useful life	3 years	3 years
Weighted Average Remaining Useful Life	3 years 9 months 18 days	2 years 9 months 18 days

Intangible Assets, Net - Amorti

Intangible Assets, Net - Amortization (Details) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
Periodic amortization that will be charged to expense over the remaining life of the intangible assets
2,016	$ 4,024
2,017	3,660
2,018	2,672
2,019	1,951
2,020	1,274
Thereafter	1,684
Net Carrying Value	$ 15,265	$ 7,530

Goodwill (Details)

Goodwill (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Goodwill
Beginning balance	$ 28,454	$ 14,786
Additions associated with acquisitions	27,888	13,668
Ending balance	$ 56,342	$ 28,454

Accrued Expenses and Other Cu57

Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
Accrued Expenses and Other Current Liabilities
Professional fees	$ 411	$ 963
Consulting fees/cutomer service fees/provider fees	869	1,118
Legal fees	1,056	389
Interest payable	287	140
Earnout and compensation	2,449
Lease abandonment	433
Deferred revenue	831
Other	1,861	1,308
Total	$ 8,197	$ 3,918

Long Term Bank and Other Debt -

Long Term Bank and Other Debt - Summary (Details) $ / shares in Units, $ in Thousands	Dec. 22, 2015item$ / sharesshares	Jul. 15, 2015USD ($)	Apr. 24, 2015item$ / sharesshares	May. 02, 2014item$ / sharesshares	May. 01, 2014USD ($)	Apr. 30, 2015USD ($)	Sep. 30, 2014USD ($)	May. 31, 2014USD ($)item$ / sharesshares	Dec. 31, 2015USD ($)	Dec. 31, 2014USD ($)	Dec. 31, 2013USD ($)	Jan. 01, 2016	May. 31, 2015USD ($)
Long-term bank and other debt
Total									$ 26,477	$ 25,873
Less: current portion									(1,250)	(833)
Long term bank and other debt									25,227	25,040
Drawdown on facility									6,800	19,700	$ 3,000
Common stock warrants
Long-term bank and other debt
Number of affiliates of lender granted warrants | item	1		1	2
Number of shares that may be exercised from warrants | shares				131,239
Number of shares issued upon exercise of warrants | shares	54,830		59,281
Exercise price of warrants (in dollars per share) | $ / shares	$ 2.95		$ 2.95	$ 2.95
Term of warrants				10 years
AmeriDoc
Long-term bank and other debt
Debt incurred upon acquisition					$ 3,500
SVB
Long-term bank and other debt
Loan origination costs										300
Loan origination costs amortized									100	100
Line of credit | Revolving Advance facility | SVB
Long-term bank and other debt
Total									6,500	4,700			$ 11,500
Maximum borrowings								$ 12,000
Borrowing base as percentage of monthly recurring revenue								300.00%
Repayments		$ 5,000
Line of credit | Revolving Advance facility | SVB | Prime Rate
Long-term bank and other debt
Basis spread on variable rate (as a percent)								0.75%
Line of credit | Term Loan facility | SVB
Long-term bank and other debt
Total									4,167	5,000
Maximum borrowings								$ 5,000
Number of monthly payments of principal and interest after initial payment | item								47
Line of credit | Term Loan facility | SVB | Prime Rate
Long-term bank and other debt
Basis spread on variable rate (as a percent)								1.00%
Mezzanine Term Loan | SVB
Long-term bank and other debt
Face amount								$ 13,000
Drawdown on facility							$ 13,000
Interest rate (as a percent)								10.00%
Mezzanine Term Loan | SVB | Common stock warrants
Long-term bank and other debt
Number of affiliates of lender granted warrants | item								2
Number of shares that may be exercised from warrants | shares								131,239
Exercise price of warrants (in dollars per share) | $ / shares								$ 2.95
Term of warrants								10 years
Mezzanine Term Loan | Term Loan facility | SVB
Long-term bank and other debt
Debt discount									190	327
Total									12,810	12,673
Subordinated Promissory Note
Long-term bank and other debt
Total									3,000	$ 3,500
Subordinated Promissory Note | AmeriDoc
Long-term bank and other debt
Interest rate (as a percent)						10.00%						7.00%
Debt incurred upon acquisition						$ 3,500
Repayments									$ 500

Long Term Bank and Other Debt59

Long Term Bank and Other Debt - Payments Due (Details) $ in Thousands	Dec. 31, 2015USD ($)
Long Term Bank and Other Debt
2,016	$ 1,250
2,017	23,750
2,018	1,250
2,019	417
Total	$ 26,667

Related Party Transaction (Deta

Related Party Transaction (Details) - USD ($) $ / shares in Units, $ in Millions	1 Months Ended	12 Months Ended
	May. 31, 2013	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Related party transactions
Options exercised (in shares)		270,545	786,074	737,597
Exercise price (in dollars per share)			$ 0.96	$ 0.80
Loan to officer for exercise of stock options
Related party transactions
Note receivable issued to related party	$ 0.3
Interest rate (as percent)	2.00%
Amount of debt outstanding			$ 0.3
Loan to officer for exercise of stock options | Employee stock options
Related party transactions
Options exercised (in shares)	312,474
Exercise price (in dollars per share)	$ 0.80

Leases and Contractual Obliga61

Leases and Contractual Obligations (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Feb. 28, 2015	Nov. 30, 2014
Future minimum lease payments under non cancelable operating leases
2,016	$ 1,682
2,017	1,221
2,018	1,069
2,019	898
2,020	934
2021 and thereafter	4,538
Total	10,342
Rent expense	$ 1,300	$ 800	$ 500
SVB | Office Lease - Purchase, NY
Future minimum lease payments under non cancelable operating leases
Letter of credit issued in lieu of cash deposit					$ 300
SVB | Office Lease - Dallas, TX
Future minimum lease payments under non cancelable operating leases
Letter of credit issued in lieu of cash deposit				$ 1,000

Convertible Preferred Stock (62

Convertible Preferred Stock (the "Preferred Stock") (Details) - USD ($)	Jul. 07, 2015	Jun. 17, 2015	Sep. 10, 2014	Aug. 31, 2014	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2015	Dec. 31, 2012
Temporary equity
Number of shares issued upon conversion of convertible stock	25.5
Shares Authorized					50,479,286
Shares Outstanding					50,452,939
Common Shares Upon Conversion					25,450,440
Liquidation Preference					$ 117,913,630
Share price threshold of initial public offering for automatic conversion into common stock (in dollars per share)					$ 12
Threshold of proceeds from initial public offering for automatic conversion into common stock					$ 75,000,000
Multiple applied to adjusted original issue price to determine value in event of liquidation of preferred stock					1.23
Multiple applied to original issue price of preferred stock used to determine value for remaining assets after liquidation (in dollars per share)					3
Maximum number of days following liquidating event structured as sale of assets that shareholders may elect to redeem shares in exchange for liquidation rights					90 days
Minimum percentage of any series of Preferred Stock issued and outstanding for application of protective provisions					25.00%
Convertible Preferred Stock
Temporary equity
Number of shares issued upon conversion of convertible stock	25,500,000	25,500,000
Shares Authorized					50,479,286		50,479,286
Shares Outstanding					50,452,939	37,590,286	0	31,371,102
Liquidation Preference					$ 117,914,000
Share price threshold of initial public offering for automatic conversion into common stock (in dollars per share)		$ 12
Threshold of proceeds from initial public offering for automatic conversion into common stock		$ 75,000,000
Convertible preferred stock, excluding Series F
Temporary equity
Dividend rate (as a percent)					7.50%
Convertible Preferred Stock Series A
Temporary equity
Shares Authorized					418,634
Shares Outstanding					418,634
Common Shares Upon Conversion					1,628,498
Liquidation Preference					$ 5,232,925
Original Issue Price (in dollars per share)					$ 7.425
Conversion Price (in dollars per share)					$ 1.9090
Number of Shares of Common Stock Issued for each Preferred Share Upon Conversion					3.8900
Convertible Preferred Stock Series A1
Temporary equity
Shares Authorized					53,957
Shares Outstanding					53,957
Common Shares Upon Conversion					282,689
Liquidation Preference					$ 918,955
Original Issue Price (in dollars per share)					$ 10
Conversion Price (in dollars per share)					$ 1.9090
Number of Shares of Common Stock Issued for each Preferred Share Upon Conversion					5.2391
Adjusted original issue price of preferred stock used to determine value in event of liquidation of preferred stock (in dollars per share)					$ 13.625
Multiple applied to adjusted original issue price to determine value in event of redemption of preferred stock					1.25
Convertible Preferred Stock Series B
Temporary equity
Shares Authorized					263,839
Shares Outstanding					263,839
Common Shares Upon Conversion					1,790,050
Liquidation Preference					$ 5,768,378
Original Issue Price (in dollars per share)					$ 12.95
Conversion Price (in dollars per share)					$ 1.9090
Number of Shares of Common Stock Issued for each Preferred Share Upon Conversion					6.7846
Adjusted original issue price of preferred stock used to determine value in event of liquidation of preferred stock (in dollars per share)					$ 17.775
Convertible Preferred Stock Series C1
Temporary equity
Shares Authorized					18,287,483
Shares Outstanding					18,267,759
Common Shares Upon Conversion					7,991,496
Liquidation Preference					$ 15,253,579
Original Issue Price (in dollars per share)					$ 0.835
Conversion Price (in dollars per share)					$ 1.9090
Number of Shares of Common Stock Issued for each Preferred Share Upon Conversion					0.4375
Convertible Preferred Stock Series D
Temporary equity
Shares Authorized					12,339,204
Shares Outstanding					12,339,204
Common Shares Upon Conversion					5,397,962
Liquidation Preference					$ 18,600,005
Original Issue Price (in dollars per share)					$ 1.5074
Conversion Price (in dollars per share)					$ 3.4458
Number of Shares of Common Stock Issued for each Preferred Share Upon Conversion					0.4375
Convertible Preferred Stock Series E
Temporary equity
Shares Authorized					6,227,169
Shares Outstanding					6,227,169
Common Shares Upon Conversion					2,724,165
Liquidation Preference					$ 15,000,005
Number of new shares issued during period						6,227,169
Original Issue Price (in dollars per share)					$ 2.4088
Conversion Price (in dollars per share)					$ 5.5063
Number of Shares of Common Stock Issued for each Preferred Share Upon Conversion					0.4375
Convertible Preferred Stock Series F
Temporary equity
Shares Authorized					12,889,000
Shares Outstanding					12,882,377
Common Shares Upon Conversion					5,635,580
Liquidation Preference					$ 57,139,783
Accrued and accumulated dividends				$ 13,800,000
Rate at which new series of Preferred stock received in exchange for accrued dividends (in dollars per share)				$ 0.50
Rate at which accrued dividends were converted into new series of preferred stock (in dollars per share)				$ 1
Number of new shares issued during period			1,554,000		11,329,068
Original Issue Price (in dollars per share)					$ 4.4355
Conversion Price (in dollars per share)					$ 10.1391
Number of Shares of Common Stock Issued for each Preferred Share Upon Conversion					0.4375
Multiple applied to adjusted original issue price to determine value in event of liquidation of preferred stock					4.4355

Common Stock and Stockholders63

Common Stock and Stockholders’ Equity (Deficit) - Capitalization (Details) $ / shares in Units, $ in Millions	Jul. 07, 2015USD ($)$ / sharesshares	Jun. 17, 2015USD ($)$ / sharesshares	Dec. 31, 2015$ / sharesshares	Dec. 31, 2014$ / sharesshares	Dec. 31, 2013$ / shares
Capitalization
Issuance of stock under IPO (in shares)	9,487,500
Price of stock issued (in dollars per share) | $ / shares			$ 7.09	$ 5.53	$ 1.07
Common stock par value (in dollars per share) | $ / shares			$ 0.001	$ 0.001
Reverse stock split		0.437
Number of common stock shares authorized		75,000,000	75,000,000	75,000,000
Number of preferred stock shares authorized		50,479,286
IPO And Over-Allotment Option
Capitalization
Issuance of stock under IPO (in shares)	9,487,500	9,487,500
Price of stock issued (in dollars per share) | $ / shares	$ 19	$ 19
Proceeds received, net of issuance costs | $	$ 163.1	$ 163.1
Underwriting discounts and commissions | $	12.6	12.6
Other offering expenses | $	$ 4.5	$ 4.5

Common Stock and Stockholders64

Common Stock and Stockholders’ Equity (Deficit) - Temporary Equity (Details) $ / shares in Units, $ in Thousands	Jul. 07, 2015shares	Jun. 17, 2015USD ($)$ / sharesshares	Dec. 31, 2015shares	Dec. 31, 2014USD ($)$ / sharesshares	Dec. 31, 2013USD ($)shares	Dec. 31, 2012USD ($)shares
Temporary equity
Share price threshold of initial public offering for automatic conversion into common stock (in dollars per share) | $ / shares				$ 12
Threshold of proceeds from initial public offering for automatic conversion into common stock | $				$ 75,000
Number of shares issued upon conversion of convertible stock	25.5
Temporary equity, shares outstanding				50,452,939
Convertible Preferred Stock
Temporary equity
Share price threshold of initial public offering for automatic conversion into common stock (in dollars per share) | $ / shares		$ 12
Threshold of proceeds from initial public offering for automatic conversion into common stock | $		$ 75,000
Number of shares issued upon conversion of convertible stock	25,500,000	25,500,000
Temporary equity, shares outstanding			0	50,452,939	37,590,286	31,371,102
Temporary equity, carrying amount | $				$ 117,914	$ 71,655	$ 53,130
Redeemable Common Stock
Temporary equity
Number of shares issued upon conversion of convertible stock	113,294	113,294
Temporary equity, shares outstanding			0	113,294	113,294	113,294
Temporary equity, carrying amount | $				$ 2,852	$ 2,852	$ 2,852
Redeemable Common Stock Series A
Temporary equity
Temporary equity, shares outstanding			59,048
Temporary equity redemption price, multiplier of stock split ratio			2.25
Temporary equity redemption price, multiplier of stock price			2.2859
Temporary equity, carrying amount | $				800
Redeemable Common Stock Series B
Temporary equity
Temporary equity, shares outstanding			54,246
Temporary equity redemption price, multiplier of stock split ratio			2.25
Temporary equity redemption price, multiplier of stock price			2.2859
Temporary equity, carrying amount | $				$ 2,100

Common Stock and Stockholders65

Common Stock and Stockholders’ Equity (Deficit) - Warrants (Details) - Common stock warrants $ / shares in Units, $ in Millions	Dec. 22, 2015item$ / sharesshares	Apr. 24, 2015item$ / sharesshares	May. 02, 2014USD ($)item$ / sharesshares
Warrants
Number of warrants issued			131,239
Number of shares that may be exercised from warrants			131,239
Number of shares issued upon exercise of warrants	54,830	59,281
Cashless exercise of warrants (in shares)	65,619	65,620
Exercise price of warrants (in dollars per share) | $ / shares	$ 2.95	$ 2.95	$ 2.95
Number of affiliates of lender granted warrants | item	1	1	2
Term of warrants			10 years
Fair value of common stock warrants | $			$ 0.2

Common Stock and Stockholders66

Common Stock and Stockholders’ Equity (Deficit) - Stock Plan and Stock Options (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Shares Available for Grant
Balance, beginning of period (in shares)	741,971	694,280	331,478
Increase in Plan authorized shares	2,493,337	1,621,795	1,099,200
Stock options grants (in shares)	(1,522,581)	(1,574,104)	(736,398)
Stock options cancelled (in shares)	240,064
Stock options expired (in shares)	33,599
Balance, end of period (in shares)	1,986,390	741,971	694,280	331,478
Number of Shares Outstanding
Balance, beginning of period (in shares)	2,875,106	2,115,069	2,147,391
Stock option grants (in shares)	1,522,581	1,574,104	736,398
Stock option exercised (in shares)	(270,545)	(786,074)	(737,597)
Stock options cancelled (in shares)	(240,064)	(27,993)	(31,123)
Stock options expired (in shares)	(33,599)
Balance, end of period (in shares)	3,853,479	2,875,106	2,115,069	2,147,391
Vested or expected to vest at end of period (in shares)	3,609,059
Exercisable as of end of period (in shares)	1,087,238
Weighted-Average Exercise Price
Balance, beginning of period (in dollars per share)	$ 3.73	$ 1.14	$ 1.12
Stock option grants (in dollars per share)		5.53	1.07
Stock option exercised (in dollars per share)		0.96	0.80
Stock options cancelled (in dollars per share)		1.60	1.01
Balance, end of period (in dollars per share)	7.62	$ 3.73	$ 1.14	$ 1.12
Vested or expected to vest at end of period (in dollars per share)	7.47
Exercisable as of end of period (in dollars per share)	$ 2.84
Weighted-average remaining contractual life in Years
Weighted-average remaining contractual life (in years)	8 years 6 months 15 days	8 years 4 months 17 days	8 years 3 months 11 days	7 years 10 months 28 days
Vested or expected to vest at end of period (in years)	8 years 6 months 4 days
Exercisable as of end of period (in years)	7 years 5 months 5 days
Aggregate Intrinsic Value
Aggregate Intrinsic Value	$ 41,894	$ 6,758	$ 4,058	$ 1,425
Vested or expected to vest at end of period	39,715
Exercisable as of end of period	16,440
Grant-date fair value of stock options granted during the period	$ 10,800	$ 4,800	$ 700
Fair value assumptions
Volatility, minimum (as a percent)	45.40%	53.30%	51.00%
Volatility, maximum (as a percent)	51.00%	53.70%	53.40%
Expected life (in years)	6 years 10 months 24 days	7 years	7 years
Risk-free interest rate, minimum	1.85%	1.92%	1.15%
Risk-free interest rate, maximum	2.06%	2.30%	2.21%
Weighted-average fair value of underlying common stock	$ 7.09	$ 5.53	$ 1.07
Maximum
Stock Plan and Stock Options
Exercisable period (in years)	10 years

Common Stock and Stockholders67

Common Stock and Stockholders’ Equity (Deficit) - Compensation Costs (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Compensation costs charged as an expense
Stock-based compensation	$ 3,075	$ 533	$ 298
Unrecognized compensation cost	$ 11,200
Period over which unrecognized compensation cost is expected to be recognized	3 years 2 months 12 days
Administrative And Marketing
Compensation costs charged as an expense
Stock-based compensation	$ 83	23	11
Sales
Compensation costs charged as an expense
Stock-based compensation	422	75	14
Technology And Development
Compensation costs charged as an expense
Stock-based compensation	337	39	12
General and administrative expenses
Compensation costs charged as an expense
Stock-based compensation	$ 2,233	$ 396	$ 261

Income Taxes - Components of Lo

Income Taxes - Components of Loss (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Components of loss from continuing operations before income taxes
United States	$ (57,984)	$ (16,649)	$ (5,925)

Income Taxes - Statutory Income

Income Taxes - Statutory Income Tax Rate Reconciliation (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Reconciliations of the statutory federal income tax rate and effective tax rate
Tax at federal statutory rate	$ (19,715)	$ (5,661)	$ (2,014)
State and local tax	(3,189)	(916)	(326)
Non‑deductible stock compensation	688	210	116
Non‑deductible expenses	158	87	41
Change in valuation allowance	22,094	6,668	2,277
Income tax provision	$ 36	$ 388	$ 94

Income Taxes - Deferred Tax Ass

Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
Deferred tax assets (liabilities):
Net operating loss carryforwards	$ 47,053	$ 21,381
Accrued expenses	926	705
Stock‑based compensation	451	198
Amortization of intangible assets	(3,072)	(87)
Depreciation of property and equipment	(152)	(321)
Valuation allowance	(46,477)	(22,358)
Other	86
Net deferred tax assets (liabilities)	$ (1,185)	$ (482)

Income Taxes - Valuation Allowa

Income Taxes - Valuation Allowance and Carryforwards (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Income Taxes
Increase in valuation allowance	$ 24.1	$ 6.7	$ 2.3
Increase in valuation allowance in association with acquisition activity	2
Operating loss carryforwards	120
Uncertain tax position	0	0	$ 2.3
Unrecognized tax benefit for income tax penalties and interest expense	0.6	$ 0.5
Unrecognized Tax Benefits, Interest on Income Taxes Expense	$ 0.1

Net Loss Per Share (Details)

Net Loss Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	Jul. 07, 2015	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Net Loss per Share
Net loss		$ (58,020)	$ (17,037)	$ (6,019)
Preferred stock dividend			(2,920)	(3,624)
Accretion of preferred stock			(168)	(197)
Net loss		$ (58,020)	$ (20,125)	$ (9,840)
Weighted-average shares used to compute basic and diluted net loss per share		19,917,348	1,962,845	1,222,268
Net loss per share, basic and diluted		$ (2.91)	$ (10.25)	$ (8.05)
Calculation of basic and diluted pro forma net loss per share
Issuance of stock under IPO (in shares)	9,487,500
Net loss		$ (58,020)	$ (20,125)	$ (9,840)
Unaudited pro forma basic and diluted net loss per share		$ (1.53)
Unaudited pro forma net loss per share - weighted average shares		37,817,061
Basic net loss per share - weighted average shares		19,917,348	1,962,845	1,222,268
IPO		4,861
Preferred conversion		13,039

401(k) Plan (Details)

401(k) Plan (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
401(k) Plan
Minimum age of employee eligible to participate in the plan	21 years
Employer contributions (as a percent)	100.00%
Percentage of eligible compensation, matched by the employer	4.00%
Matching contribution made	$ 0.7	$ 0.4

Legal Matters (Details)

Legal Matters (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2015USD ($)lawsuit	Dec. 31, 2014USD ($)	Dec. 31, 2013USD ($)
Revenues from external customers
Number of active lawsuits filed by entity | lawsuit	2
Revenues	$ 77,384	$ 43,528	$ 19,906
Geographic Concentration Risk | Texas
Revenues from external customers
Revenues	$ 12,600	$ 10,000	$ 2,300
Concentration risk (as a percent)	16.00%	23.00%	12.00%